Quarterly Report • Feb 22, 2018
Quarterly Report
Open in ViewerOpens in native device viewer
Strictly Confidential
KBC Group I Quarterly Report – 4Q2017 I p.1
Summary 4
The core of our strategy 5
Overview of our results and balance sheet 6
Analysis of the quarter 7
Analysis of the year-to-date period 10
Risk statement 10
Our views and guidance 11
Additional information 11
Consolidated income statement 13
Consolidated statement of comprehensive income 14
Consolidated balance sheet 15
Consolidated statement of changes in equity 16
Consolidated cash flow statement 17
Notes on statement of compliance and changes in accounting policies 17
Notes on segment reporting 20
Other notes 21
Credit risk 32
Solvency 38
Income statement per business unit 42
Details of ratios and terms 50
'I, Rik Scheerlinck, Chief Financial Officer of the KBC Group, certify on behalf of the Executive Committee of KBC Group NV that, to the best of my knowledge, the abbreviated financial statements included in the quarterly report are based on the relevant accounting standards and fairly present in all material respects the financial condition and results of KBC Group NV including its consolidated subsidiaries, and that the quarterly report provides a fair view of the main events, the main transactions with related parties in the period under review and their impact on the abbreviated financial statements, and an overview of the main risks and uncertainties for the remainder of the current year.'
The expectations, forecasts and statements regarding future developments that are contained in this report are, of course, based on assumptions and are contingent on a number of factors that will come into play in the future. Consequently, the actual situation may turn out to be (substantially) different.
[email protected] KBC Group NV, Investor Relations Office, Havenlaan 2, 1080 Brussels, Belgium
This report contains information that is subject to transparency regulations for listed companies. Date of release: 22 February 2018
Check this document's authenticity at www.kbc.com/en/authenticity .
Strictly Confidential
Report for 4Q2017 and FY2017
Against the background of sustained economic expansion, only moderately rising inflation, a stronger euro and continuing low interest rates, KBC posted a net profit of 399 million euros in the fourth quarter of 2017. The quarter under review was impacted by a one-off, upfront negative effect of 211 million euros due to the Belgian corporate tax reform. Excluding this one-off item, the net result amounted to 610 million euros for the fourth quarter of 2017. Our core businesses performed well once again, with costs remaining under control and asset quality remaining strong as demonstrated by a loan loss provisions release. Adding the fourth-quarter result to the results for the first three quarters of the year brought the net result to 2 575 million euros for the full year, up 6% on the 2 427 million euros recorded for full year 2016. Our liquidity position remained robust, while our solid solvency position is reflected in a common equity ratio (fullyloaded) of 16.3% at year-end 2017.
We will propose to the General Meeting of Shareholders in May the total (gross) dividend for 2017 be set at 3 euros per share, meaning that – following payment of the interim dividend of 1 euro per share in November 2017 – the final gross dividend to be paid in May will be 2 euros per share. We will also propose buying back 2.7 million shares to offset shareholder dilution caused by the capital increases for staff. This results in a pay-out ratio of 59%.
'We booked a net profit of 399 million euros in the fourth quarter. This result was impacted by the one-off negative effect of 211 million euros due to the Belgian corporate tax reform (which will have a recurring positive impact on income taxes for the Belgian entities going forward). Excluding this one-off item, our net result amounted to a good 610 million euros. It was supported by a pick-up in fee and commission income, a strong level of income generated by the dealing room and an impairment release, but also included a typical end-of-year hike in costs.
Combined with the 630 million euros recorded in the first quarter, the exceptionally strong 855 million euros in the second quarter and the 691 million euros in the third quarter, this brings our net result for full year 2017 to an excellent 2 575 million euros, up 6% on the figure for 2016.
On the regulatory front, there was a more benign outcome to the Basel IV discussions. We estimate the
impact of Basel IV on KBC to be roughly 8 billion euros in additional risk weighted assets on a fully loaded basis as at year-end 2017, which corresponds to a risk weighted assets inflation of 9% and an impact of -1.3% on the common equity ratio. This figure is based on our current interpretation of Basel IV, a static balance sheet and the current economic environment. It also does not take into account possible management actions. For our capital deployment plan, the 1% Basel IV buffer relative to our peer group is no longer required. Taking into account the updated median common equity ratio of our 12 peers, our 'own capital target' and 'reference capital position' have been lowered to 14% and 16%, respectively. Regarding IFRS9, we expect a negative impact of its first-time application on our fully loaded common equity ratio of approximately 41 basis points.
We will propose to the General Meeting of Shareholders in May the total (gross) dividend for 2017 be set at 3 euros per share, meaning that – following payment of the interim dividend of 1 euro per share in November 2017 – the final gross dividend to be paid in May will be 2 euros per share. We will also propose buying back 2.7 million shares to offset shareholder dilution caused by the capital increases for staff. This results in a pay-out ratio of 59%. We reconfirm our policy to pay out at least 50% of our consolidated net profit to our shareholders in the form of dividends and in coupons on the additional tier-1 instrument.
Our success is based on the trust that our clients continue to place in our company. I'd like to explicitly thank all our clients for that trust and to assure them that we are more focused than ever in our efforts to become the reference in bank-insurance in all our core countries. In the years ahead, we will build on the momentum of previous years, thanks to our successful client-centric bankinsurance model, underpinned by our very solid liquidity position and strong capital base and supported by our 42 000-strong workforce worldwide.'
| Overview KBC Group (consolidated, IFRS) | 4Q2017 | 3Q2017 | 4Q2016 | FY2017 | FY2016 |
|---|---|---|---|---|---|
| Net result (in millions of EUR) | 399 | 691 | 685 | 2 575 | 2 427 |
| Basic earnings per share (in EUR) | 0.92 | 1.62 | 1.61 | 6.03 | 5.68 |
| Breakdown of the net result by business unit (in millions of EUR) | |||||
| Belgium | 336 | 455 | 439 | 1 575 | 1 432 |
| Czech Republic | 167 | 170 | 131 | 702 | 596 |
| International Markets | 74 | 78 | 139 | 444 | 428 |
| Group Centre | -179 | -12 | -24 | -146 | -29 |
| Parent shareholders' equity per share (in EUR, end of period) | 41.6 | 40.6 | 38.1 | 41.6 | 38.1 |
Our core strategy remains focused on providing bank-insurance products and services to retail, SME and mid-cap clients in our core countries of Belgium, Bulgaria, the Czech Republic, Hungary, Ireland and Slovakia.
Our strategy consists of four interacting cornerstones:
We provide a full overview of our IFRS consolidated income statement and balance sheet in the 'Consolidated financial statements' section of the quarterly report. Condensed statements of comprehensive income, changes in shareholders' equity, as well as several notes to the accounts, are also available in the same section.
| Consolidated income statement, IFRS KBC Group (in millions of EUR) |
4Q2017 | 3Q2017 | 2Q2017 | 1Q2017 | 4Q2016 | FY 2017 |
FY 2016 |
|---|---|---|---|---|---|---|---|
| Net interest income | 1 029 | 1 039 | 1 028 | 1 025 | 1 057 | 4 121 | 4 258 |
| Non-life insurance (before reinsurance) | 152 | 188 | 179 | 187 | 178 | 706 | 628 |
| Earned premiums Technical charges |
384 -232 |
378 -190 |
369 -190 |
360 -173 |
363 -185 |
1 491 -785 |
1 410 -782 |
| Life insurance (before reinsurance) | -3 | -3 | -24 | -28 | -44 | -58 | -152 |
| Earned premiums Technical charges |
410 -414 |
282 -284 |
267 -291 |
312 -341 |
413 -457 |
1 271 -1 330 |
1 577 -1 728 |
| Ceded reinsurance result | -10 | 16 | -10 | -4 | -15 | -8 | -38 |
| Dividend income | 8 | 11 | 30 | 15 | 19 | 63 | 77 |
| Net result from financial instruments at fair value through P&L | 235 | 182 | 249 | 191 | 224 | 856 | 540 |
| Net realised result from available-for-sale assets | 51 | 51 | 52 | 45 | 8 | 199 | 189 |
| Net fee and commission income | 430 | 408 | 430 | 439 | 376 | 1 707 | 1 450 |
| Other net income | -14 | 4 | 47 | 77 | 101 | 114 | 258 |
| Total income | 1 878 | 1 896 | 1 980 | 1 946 | 1 903 | 7 700 | 7 211 |
| Operating expenses | -1 021 | -914 | -910 | -1 229 | -963 | -4 074 | -3 948 |
| Impairment | -2 | -31 | 71 | -8 | -73 | 30 | -201 |
| on loans and receivables on available-for-sale assets |
30 -3 |
-15 -6 |
78 -2 |
-6 -1 |
-54 -4 |
87 -12 |
-126 -55 |
| on goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other | -29 | -11 | -5 | 0 | -15 | -45 | -20 |
| Share in results of associated companies and joint ventures | -5 | 8 | 3 | 5 | 5 | 11 | 27 |
| Result before tax | 850 | 959 | 1 144 | 715 | 871 | 3 667 | 3 090 |
| Income tax expense | -451 | -268 | -288 | -85 | -186 | - 1 093 | -662 |
| Net post-tax result from discontinued operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Result after tax | 398 | 691 | 855 | 630 | 685 | 2 575 | 2 428 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 399 | 691 | 855 | 630 | 685 | 2 575 | 2 427 |
| Basic earnings per share (EUR) Diluted earnings per share (EUR) |
0.92 0.92 |
1.62 1.62 |
2.01 2.01 |
1.47 1.47 |
1.61 1.61 |
6.03 6.03 |
5.68 5.68 |
| Key consolidated balance sheet figures KBC Group (in millions of EUR) |
31-12-2017 | 30-09-2017 | 30-06-2017 | 31-03-2017 | 31-12-2016 |
|---|---|---|---|---|---|
| Total assets | 292 342 | 296 885 | 296 479 | 287 293 | 275 200 |
| Loans and advances to customers | 141 502 | 140 466 | 139 350 | 135 304 | 133 231 |
| Securities (equity and debt instruments) | 67 743 | 69 273 | 70 898 | 72 329 | 73 262 |
| Deposits from customers and debt certificates | 193 968 | 190 824 | 189 938 | 181 722 | 177 730 |
| Technical provisions, before reinsurance | 18 641 | 18 696 | 18 905 | 19 234 | 19 657 |
| Liabilities under investment contracts, insurance | 13 552 | 13 294 | 13 339 | 13 128 | 12 653 |
| Parent shareholders' equity | 17 403 | 17 003 | 16 665 | 16 506 | 15 957 |
| Selected ratios for the KBC group (consolidated) | FY2017 | FY2016 |
|---|---|---|
| Profitability and efficiency | ||
| Return on equity | 17%* | 18% |
| Cost/income ratio, banking (when excluding certain non-operating items) | 54% (55%) | 55% (57%) |
| Combined ratio, non-life insurance | 88% | 93% |
| Solvency | ||
| Common equity ratio according to Basel III Danish Compromise method (phased-in/fully loaded) | 16.5%/16.3% | 16.2%/15.8% |
| Common equity ratio according to FICOD method (fully loaded) | 15.1% | 14.5% |
| Leverage ratio according to Basel III (fully loaded) | 6.1% | 6.1% |
| Credit risk | ||
| Credit cost ratio** | -0.06% | 0.09% |
| Impaired loans ratio | 6.0% | 7.2% |
| for loans more than 90 days overdue | 3.4% | 3.9% |
| Liquidity | ||
| Net stable funding ratio (NSFR) | 134% | 125% |
| Liquidity coverage ratio (LCR) | 139% | 139% |
* 18% excluding the one-off, upfront negative effect of 211m euros due to the Belgian corporate income tax reform.
** Negative figure indicates a net impairment release (with positive impact on the results).
The net result for the quarter amounted to 399 million euros, compared to 691 million euros in the previous quarter and 685 million euros in the corresponding quarter a year earlier.
Note: the results of the recently acquired UBB and Interlease entities in Bulgaria are included in the group's results for the second half of 2017 (net result of 13 million euros in 4Q2017). UBB and Interlease were included in the balance sheet as of 30 June 2017.
Our total income was in line with the figure for the previous quarter, as higher net fee and commission income and strong trading and fair value income were offset by a lower level of net interest income and a drop in technical insurance income (the third quarter had benefited from provision releases). Other net income was affected by an additional provision of 61.5 million euros being set aside for the tracker mortgage review in Ireland (compared to an additional provision of 54.4 million euros in the third quarter).
Net interest income amounted to 1 029 million euros in the quarter under review. Excluding the dealing room effect, net interest income roughly stabilised quarter-on-quarter and increased by 1.5% yearon-year. The effect of the persistent low reinvestment yields and negative pressure on commercial loan margins was mitigated by good loan volume growth, lower funding costs, the positive impact of rate hikes in the Czech Republic and (year-on-year) the positive effect of the consolidation of UBB/Interlease. Our net interest margin came to 1.83% for the quarter under review, i.e. stable quarter-onquarter but down 7 basis points on the year-earlier figure. Excluding the dealing room effect, our net interest margin amounted to 1.99% in 4Q2017. As already mentioned, interest income continued to be supported by loan volume growth: our total volume of lending rose by 1% quarter-on-quarter and by 5% year-on-year, with growth in all business units. Deposits went up 2% quarter-on-quarter and 8% year-on-year, with increases in all business units. Excluding UBB/Interlease, the year-on-year organic growth of loans would have been 4% and the year-on-year growth of deposits some 7%.
Technical income from our non-life and life insurance activities
(earned premiums less technical charges, plus the ceded reinsurance result) stood at 139 million euros in the quarter under review. Non-life insurance activities contributed 142 million euros to this technical insurance income figure, 31% less than in the previous quarter, since that quarter had included a one-off release of non-life provisions in Belgium totalling 26 million euros. The non-life insurance technical result was down 12% year-on-year, with the increased levels of non-life premium income in almost all core countries being offset by higher technical provisions and a lower reinsurance result. Our combined ratio for full year 2017 came to an exceptionally good 88%, compared to 93% for full year 2016. Technical insurance income from our life insurance activities stood at -3 million euros, unchanged on its level of the previous quarter (which had benefited from a 23 million release of life provisions) and better than the -44 million euros posted in the year-earlier quarter. Sales of life insurance products were 45% higher than in the previous quarter, and were up 13% on the year-earlier quarter, with sales of both guaranteed interest products and unit-linked products increasing. As a result, the share of guaranteed interest products in total sales of life insurance products stood at 54% in the fourth quarter of 2017, with unit-linked products accounting for the remaining 46%.
At 430 million euros, net fee and commission income remained robust. Year-on-year, it was up 14%, thanks mainly to the contribution made by our asset management activities in Belgium, higher securities-related fees and, to a lesser extent, to higher payment service fees in a number of countries and the inclusion of UBB/Interlease in the figures (accounting for 11 million euros in the fourth quarter of 2017). Compared to the previous quarter, there was an increase of 5%, which was primarily attributable to entry fees in the asset management business and securities-related fees. Note that the previous quarter had been adversely impacted by the holiday season. At the end of December 2017, our total assets under management stood at 219 billion euros, up 1% quarter-on-quarter and 3% year-on-year, due in both cases mainly to the positive price performance.
All other income items amounted to an aggregate 280 million euros, compared to 248 million euros in the previous quarter and 352 million euros in the year-earlier quarter. The figure for the fourth quarter of 2017 included a relatively high 51 million euros in gains realised on the sale of available-for-sale securities (predominantly on shares), 8 million euros in dividend income and -14 million euros in other net income. The latter was impacted by the booking of an additional provision of 61.5 million related to the industry wide review of tracker rate mortgages originated in Ireland before 2009 (the previous quarter had also been affected to the amount of 54.4 million euros). It also included the 235-million-euro net result from financial instruments at fair value (trading and fair value income). This figure was up on the 224 million euros recorded in the year-earlier quarter and on the 182 million euros recorded in the previous quarter, in both cases mainly due to robust dealing room income.
The cost/income ratio of our banking activities stood at a solid 54% for full year 2017, compared to 55% for full year 2016. When certain non-operating items are excluded (mark-to-market of derivatives used for asset/liability management purposes, the effect of liquidating group companies, etc.), our adjusted cost/income ratio for 2017 amounted to 55%, compared to 57% for 2016.
At 1 021 million euros, operating expenses in the fourth quarter were up 12% quarter-on-quarter and 6% year-on-year (disregarding UBB/Interlease, expenses were up by just 4% year-on-year). The increased level of costs quarter-on-quarter, partly caused by higher bank taxes, was also affected by the traditional year-end cost hike (in ICT costs, marketing expenses and professional fees) and by higher staff expenses. The year-on-year increase was – over and above the impact of UBB/Interlease (20 million euros in expenses in the fourth quarter of 2017) – due to higher bank taxes, higher ICT costs and marketing expenses, and higher depreciation and amortisation charges (due to the capitalisation of some projects).
In the fourth quarter of 2017, there was a net impairment release of 30 million euros (which had a positive impact on the net result). This compares with a net addition of 15 million euros in the previous quarter and 54 million euros in the year-earlier quarter. The favourable level of impairment in the quarter under review was attributable to a 52-million-euro impairment release in Ireland (which came about mainly because of a IBNR model change, the positive movement in the 9-month average house price index and an improvement in the portfolio of non-performing loans). There were also some small net reversals of loan provisions in the Czech Republic and Hungary and a continuing low level of loan loss impairment charges in the other countries.
Consequently, the credit cost ratio for the entire group fell to a very low -0.06% for full year 2017 (a negative figure indicates a net retrieval and, hence, a positive impact on the results). Excluding KBC Bank Ireland, the credit cost ratio amounted to 0.09% for the full year 2017.
Loan quality improved further. At the end of December 2017, some 6.0% of our loan book was classified as impaired, with 3.4% being 'impaired and more than 90 days past due'. This compares with 7.2% and 3.9%, respectively, at year-end 2016.
Impairment on assets other than loans stood at 32 million euros, compared to 17 million in the previous quarter and 19 million euros in the fourth quarter of 2016.
Income taxes amounted to 451 million euros in the fourth quarter of 2017, much higher than in both reference quarters. This was due to the one-off, upfront booking of -211 million euros, caused by the reform of the Belgian corporate tax system as of 2018 (which, among other things, reduces the existing amount of deferred tax assets (impact of -243 million euros), though partly offset by the increase in dividend exemption (DBI) from 95% to 100% (impact +32 million euros)). Going forward, however, the one-off negative impact will be fully recuperated in roughly 3 years' time given a recurring positive impact on income taxes of the Belgian entities.
Our quarterly profit of 399 million euros breaks down as follows:
| Belgium | Czech Republic | International Markets | |||||
|---|---|---|---|---|---|---|---|
| Selected ratios per business unit | FY2017 | FY2016 | FY2017 | FY2016 | FY2017 | FY2016 | |
| Cost/income ratio, banking excluding certain non-operating items | 53% | 55% | 43% | 46% | 72% | 66% | |
| Combined ratio, non-life insurance | 86% | 92% | 97% | 96% | 93% | 94% | |
| Credit cost ratio* | 0.09% | 0.12% | 0.02% | 0.11% | -0.74% | -0.16% | |
| Impaired loans ratio | 2.8% | 3.3% | 2.4% | 2.8% | 19.7% | 25.4% | |
* Negative figure indicates a net impairment release (with a positive impact on the results).
A full results table is provided in the 'Additional information' section of the quarterly report. A short analysis of the results per business unit is provided in the analyst presentation (available at www.kbc.com).
At the end of December 2017, our total equity stood at 18.8 billion euros (17.4 billion euros in parent shareholders' equity and 1.4 billion euros in additional tier-1 instruments), up 1.4 billion euros on its level at the beginning of the year. The change during 2017 resulted from the inclusion of the profit for that period (+2.6 billion euros), the payment of the final dividend for 2016 in May and the decision to pay an interim dividend for 2017 in November (an aggregate -1.2 billion euros), changes in defined benefit obligations (+0.1 billion euros) and a number of minor items.
At 31 December 2017, our fully loaded common equity ratio (Basel III, under the Danish compromise) stood at a strong 16.3%. Our leverage ratio (Basel III, fully loaded) came to 6.1%. The solvency ratio for KBC Insurance under the Solvency II framework was a sound 212% at 31 December 2017.
Our liquidity position remained excellent too, as reflected in an LCR ratio of 139% and an NSFR ratio of 134% at the end of December 2017.
The net result for 2017 amounted to 2 575 million euros, compared to 2 427 million euros for 2016. Note: the result for the12 months of 2017 includes the net result of 27 million euros generated by the recently acquired UBB and Interlease entities in Bulgaria in the period July through December.
Highlights (compared to FY2016):
As we are mainly active in banking, insurance and asset management, we are exposed to a number of typical risks for these financial sectors such as – but not limited to – credit default risk, counterparty credit risk, concentration risk, movements in interest rates, currency risk, market risk, liquidity and funding risk, insurance underwriting risk, changes in regulations, operational risk, customer litigation, competition from other and new players, as well as the economy in general. Although we closely monitor and manage each of these risks within a strict risk framework containing governance and limits, they may all have a negative impact on asset values or could generate additional charges beyond anticipated levels.
At present, a number of items are considered to constitute the main challenges for the financial sector in general and, as a consequence, are also relevant to us. Regulatory uncertainty remains a dominant theme for the sector (even though the 'Basel IV' agreement in December has brought some clarification as regards future capital requirements), as does enhanced consumer protection. Another ongoing challenge remains the low interest rate environment (despite the recent uptrend), particularly for longer maturities, combined with the increased risk of asset bubbles. The financial sector also faces the potential systemic consequences of political and financial developments like Brexit or protectionist measures in the US, which will have an impact on the European economy. Financial technology is an additional challenge for the business model of traditional financial institutions. Finally, cyber risk has become one of the main threats during the past few years, not just for the financial sector, but for the economy as a whole.
Risk management data is provided in our annual reports, quarterly reports and dedicated risk reports, all of which are available at www.kbc.com.
Our view on interest rates and foreign exchange rates: the ECB will continue its QE programme until at least September 2018. Since the beginning of January 2018, the volume of these net monthly purchases has been reduced to 30 billion euros. We forecast the ECB to wait until 2019 to raise its policy rate. In the meantime, we expect the Fed to carry out three rate hikes in 2018 (each time by 25 basis points). Consequently, we believe that the US dollar will appreciate against the euro in the short term, as it will benefit from short-term interest rate support. From mid-2018 on, however, the euro will start appreciating again. Given the low inflation environment and still highly accommodating monetary policies around the world, German and US long-term bond yields are expected to rise only modestly in the period ahead. Unlike the dovish stance of the ECB, the Czech National Bank has already begun to tighten its monetary policy and is expected to continue doing so in 2018. We forecast three rate hikes for this year in the Czech Republic (of which the first one already happened in February), which will bring the repo rate to 1.25% by the end of 2018, given economic and inflationary developments – together with the fiscal stimulus that may be implemented by the new government.
Our view on economic growth: the economic environment in the euro area is favourable and, as a result, the consumer sector remains solid. The unemployment rate is steadily falling, which will further support consumption in the period ahead. Investment growth is also gaining strength. The most significant risks continue to stem from the trend of de-globalisation and from geopolitical concerns, which could create additional uncertainty and hence affect economic sentiment.
The statutory auditor, PwC Bedrijfsrevisoren bcvba/Reviseurs d'Entreprises sccrl, represented by Roland Jeanquart and Tom Meuleman, has confirmed that its audit work, which is substantially complete, has not to date revealed any significant matters that require adjustments to be made to the 2017 consolidated income statement, the condensed consolidated statement of comprehensive income for the year, the consolidated balance sheet and the consolidated statement of changes in equity and the explanatory notes, comprising a summary of significant accounting policies and other explanatory notes included in this press release.
Financial calendar for 2018:
KBC Group Consolidated financial statements according to IFRS 4Q 2017 and FY2017
| (in millions of EUR) | e Note | 2017 | 2016 | 4Q 2017 | 3Q 2017 | 4Q 2016 |
|---|---|---|---|---|---|---|
| Net interest income | 3.1 | 4 121 | 4 258 | 1 029 | 1 039 | 1 057 |
| Interest income | 3.1 | 6 337 | 6 642 | 1 590 | 1 605 | 1 593 |
| Interest expense | 3.1 | - 2 216 | - 2 384 | - 561 | - 566 | - 537 |
| Non-life insurance before reinsurance | 3.7 | 706 | 628 | 152 | 188 | 178 |
| Earned premiums Non-life | 3.7 | 1 491 | 1 410 | 384 | 378 | 363 |
| Technical charges Non-life | 3.7 | - 785 | - 782 | - 232 | - 190 | - 185 |
| Life insurance before reinsurance | 3.7 | - 58 | - 152 | - 3 | - 3 | - 44 |
| Earned premiums Life | 3.7 | 1 271 | 1 577 | 410 | 282 | 413 |
| Technical charges Life | 3.7 | - 1 330 | - 1 728 | - 414 | - 284 | - 457 |
| Ceded reinsurance result | 3.7 | - 8 | - 38 | - 10 | 16 | - 15 |
| Dividend income | 3.2 | 63 | 77 | 8 | 11 | 19 |
| Net result from financial instruments at fair value through profit or loss | 3.3 | 856 | 540 | 235 | 182 | 224 |
| Net realised result from available-for-sale assets | 3.4 | 199 | 189 | 51 | 51 | 8 |
| Net fee and commission income | 3.5 | 1 707 | 1 450 | 430 | 408 | 376 |
| Fee and commission income | 3.5 | 2 615 | 2 101 | 641 | 606 | 552 |
| Fee and commission expense | 3.5 | - 908 | - 651 | - 210 | - 198 | - 176 |
| Net other income | 3.6 | 114 | 258 | - 14 | 4 | 101 |
| TOTAL INCOME | 7 700 | 7 211 | 1 878 | 1 896 | 1 903 | |
| Operating expenses | 3.8 | - 4 074 | - 3 948 | - 1 021 | - 914 | - 963 |
| Staff expenses | 3.8 | - 2 303 | - 2 252 | - 584 | - 578 | - 581 |
| General administrative expenses | 3.8 | - 1 505 | - 1 449 | - 368 | - 268 | - 318 |
| Depreciation and amortisation of fixed assets | 3.8 | - 266 | - 246 | - 70 | - 68 | - 63 |
| Impairment | 3.10 | 30 | - 201 | - 2 | - 31 | - 73 |
| on loans and receivables | 3.10 | 87 | - 126 | 30 | - 15 | - 54 |
| on available-for-sale assets | 3.10 | - 12 | - 55 | - 3 | - 6 | - 4 |
| on goodwill | 3.10 | 0 | 0 | 0 | 0 | 0 |
| on other | 3.10 | - 45 | - 20 | - 29 | - 11 | - 15 |
| Share in results of associated companies and joint ventures | 3.11 | 11 | 27 | - 5 | 8 | 5 |
| RESULT BEFORE TAX | 3 667 | 3 090 | 850 | 959 | 871 | |
| Income tax expense | 3.12 | - 1 093 | - 662 | - 451 | - 268 | - 186 |
| RESULT AFTER TAX | 2 575 | 2 428 | 398 | 691 | 685 | |
| Attributable to minority interest | 0 | 0 | 0 | 0 | 0 | |
| Attributable to equity holders of the parent | 2 575 | 2 427 | 399 | 691 | 685 | |
| Earnings per share (in EUR) | ||||||
| Basic | 3.13 | 6,03 | 5,68 | 0,92 | 1,62 | 1,61 |
| Diluted | 3.13 | 6,03 | 5,68 | 0,92 | 1,62 | 1,61 |
Impact acquisition UBB/Interlease:
UBB/Interlease are included in the consolidated income statement as of 3Q 2017.
For more information see note 'Main changes in the scope of consolidation' (note 6.6) further in this report.
| (in millions of EUR) | 2017 | 2016 | 4Q 2017 | 3Q 2017 | 4Q 2016 |
|---|---|---|---|---|---|
| RESULT AFTER TAX | 2 575 | 2 428 | 398 | 691 | 685 |
| attributable to minority interest | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 2 575 | 2 427 | 399 | 691 | 685 |
| Other comprehensive income - to be recycled to P&L | 4 | - 196 | - 23 | 49 | 54 |
| Net change in revaluation reserve (AFS assets) - Equity | - 31 | - 57 | - 12 | - 14 | 85 |
| Net change in revaluation reserve (AFS assets) - Bonds | 38 | 26 | 153 | 54 | - 375 |
| Net change in revaluation reserve (AFS assets) - Other | 0 | 0 | 0 | 0 | 0 |
| Net change in hedging reserve (cash flow hedge) | 8 | - 201 | - 174 | 22 | 305 |
| Net change in translation differences | - 7 | 20 | 11 | - 12 | 38 |
| Net change related to associated companies & joint ventures | - 3 | 4 | 1 | - 1 | 0 |
| Other movements | - 2 | 11 | - 1 | 0 | 0 |
| Other comprehensive income - not to be recycled to P&L | 80 | - 231 | 22 | 31 | 80 |
| Net change in defined benefit plans | 86 | - 231 | 23 | 30 | 80 |
| Net change on own credit risk - liabilities designated at FV(T)PL | - 6 | 0 | - 1 | 1 | 0 |
| Net change related to associated companies & joint ventures | 0 | 0 | 0 | 0 | 0 |
| TOTAL COMPREHENSIVE INCOME | 2 658 | 2 000 | 398 | 771 | 819 |
| attributable to minority interest | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 2 658 | 2 000 | 398 | 771 | 819 |
The largest movements in other comprehensive income (12M 2017 vs. 12M 2016):
| ASSETS (in millions of EUR) | Note | 31-12-2017 | 31-12-2016 |
|---|---|---|---|
| Cash, cash balances at central banks and other demand deposits from credit institutions | 29 727 | 20 686 | |
| Financial assets | 4.1 - 4.7 | 254 753 | 246 298 |
| Held for trading | 4.1 - 4.7 | 7 431 | 9 683 |
| Designated at fair value through profit or loss | 4.1 - 4.7 | 14 484 | 14 184 |
| Available for sale | 4.1 - 4.7 | 34 156 | 36 708 |
| Loans and receivables | 4.1 - 4.7 | 167 458 | 151 615 |
| Held to maturity | 4.1 - 4.7 | 30 979 | 33 697 |
| Hedging derivatives | 4.1 - 4.7 | 245 | 410 |
| Reinsurers' share in technical provisions | 5.6 | 131 | 110 |
| Fair value adjustments of hedged items in portfolio hedge of interest rate risk (*) |
- | - 78 | 202 |
| Tax assets | 5.2 | 1 625 | 2 312 |
| Current tax assets | 5.2 | 82 | 66 |
| Deferred tax assets | 5.2 | 1 543 | 2 246 |
| Non-current assets held for sale and assets associated with disposal groups | - | 21 | 8 |
| Investments in associated companies and joint ventures | 5.2 | 240 | 212 |
| Investment property | 5.4 | 485 | 426 |
| Property and equipment | 5.4 | 2 721 | 2 451 |
| Goodwill and other intangible assets | 5.5 | 1 205 | 999 |
| Other assets | 5.1 | 1 512 | 1 496 |
| TOTAL ASSETS | 292 342 | 275 200 | |
| LIABILITIES AND EQUITY (in millions of EUR) | Note | 31-12-2017 | 31-12-2016 |
| Financial liabilities | 4.1 - 4.7 | 251 260 | 234 300 |
| Held for trading | 4.1 - 4.7 | 6 998 | 8 559 |
| Designated at fair value through profit or loss | 4.1 - 4.7 | 15 034 | 16 553 |
| Measured at amortised cost | 4.1 - 4.7 | 227 944 | 207 485 |
| Hedging derivatives | 4.1 - 4.7 | 1 284 | 1 704 |
| Technical provisions, before reinsurance | 5.6 | 18 641 | 19 657 |
| Fair value adjustments of hedged items in portfolio hedge of interest rate risk (*) |
- | - 86 | 204 |
| Tax liabilities | 5.2 | 582 | 681 |
| Current tax liabilities | 5.3 | 148 | 188 |
| Deferred tax liabilies | 5.4 | 434 | 493 |
| Provisions for risks and charges | 5.7 | 399 | 238 |
| Other liabilities | 5.8 | 2 743 | 2 763 |
| TOTAL LIABILITIES | 273 540 | 257 843 | |
| Total equity | 5.10 | 18 803 | 17 357 |
| Parent shareholders' equity | 5.10 | 17 403 | 15 957 |
| Additional Tier-1 instruments included in equity | 5.10 | 1 400 | 1 400 |
| Minority interests | - | 0 | 0 |
| TOTAL LIABILITIES AND EQUITY | 292 342 | 275 200 | |
(*) Fair value adjustments in portfolio hedge of interest rate risk: the negative amount on the asset as well as on the liability side can be explained by a negative fair value adjustment on respectively the underlying hedged assets and liabilities. The hedges are deemed to be effective, the positive leg of the hedge is reflected in the line hedging derivatives.
In order to align with the consolidated financial reporting framework (FINREP) of the European Banking Authority, the presentation of the balance sheet has been slightly changed: Cash and cash balances includes as of 2017 also other demand deposits with credit institutions and consequently has been renamed 'Cash, cash balances at central banks and other demand deposits from credit institutions'. The reference figures have been restated accordingly (shift of 538 million euros mainly from Loans and receivables). The balance sheet of 31 December 2017 includes UBB/Interlease: for more information see note 'Main changes in the scope of consolidation' (note 6.6) further in this report
of which revaluation reserve for shares 490 of which revaluation reserve for bonds 1 266
| Additional | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hedging | Own credit | Tier-1 | |||||||||||
| Revaluation | reserve | Remeasurement | risk | instruments | |||||||||
| Issued and paid | Share | Treasury | reserve | (cashflow | of defined benefit | (through | Retained | Translation | Parent share | included in | Minority | Total | |
| In millions of EUR | up share capital | premium | shares | (AFS assets) | hedges) | obligations | OCI) | earnings | differences | holders' equity | equity | interests | equity |
| 31-12-2017 | |||||||||||||
| Balance at the beginning of the period (01-01-2017) | 1 455 | 5 453 | 0 | 1 756 | - 1 347 | - 138 | - 4 | 8 751 | 31 | 15 957 | 1 400 | 0 17 357 | |
| Net result for the period | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 575 | 0 | 2 575 | 0 | 0 | 2 575 |
| Other comprehensive income for the period | 0 | 0 | 0 | - 5 | 8 | 86 | - 6 | - 2 | 2 | 84 | 0 | 0 | 84 |
| Total comprehensive income | 0 | 0 | 0 | - 5 | 8 | 86 | - 6 | 2 573 | 2 | 2 658 | 0 | 0 | 2 658 |
| Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - 1 171 | 0 | - 1 171 | 0 | 0 | - 1 171 |
| Coupon additional Tier-1 instruments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - 52 | 0 | - 52 | 0 | 0 | - 52 |
| Capital increase | 1 | 15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15 | 0 | 0 | 15 |
| Purchases of treasury shares | 0 | 0 | - 5 | 0 | 0 | 0 | 0 | 0 | 0 | - 5 | 0 | 0 | - 5 |
| Total change | 1 | 15 | - 5 | - 5 | 8 | 86 | - 6 | 1 350 | 2 | 1 446 | 0 | 0 | 1 446 |
| Balance at the end of the period | 1 456 | 5 467 | - 5 | 1 751 | - 1 339 | - 52 | - 10 | 10 101 | 33 | 17 403 | 1 400 | 0 18 803 | |
| of which revaluation reserve for shares | 460 | ||||||||||||
| of which revaluation reserve for bonds | 1 292 | ||||||||||||
| of which relating to equity method | 14 | 0 | 0 | 0 | 0 | 16 | 30 | 30 | |||||
| 31-12-2016 Balance at the beginning of the period (01-01-2016) |
1 454 | 5 437 | 0 | 1 782 | - 1 146 | 94 | 0 | 6 779 | 11 | 14 411 | 1 400 | 0 15 811 | |
| Net result for the period | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 427 | 0 | 2 427 | 0 | 0 | 2 428 |
| Other comprehensive income for the period | 0 | 0 | 0 | - 26 | - 201 | - 231 | 0 | 11 | 20 | - 427 | 0 | 0 | - 427 |
| Total comprehensive income | 0 | 0 | 0 | - 26 | - 201 | - 231 | 0 | 2 439 | 20 | 2 000 | 0 | 0 | 2 000 |
| Dividends Coupon additional Tier-1 instruments |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
- 418 - 52 |
0 0 |
- 418 - 52 |
0 0 |
0 0 |
- 418 - 52 |
| Capital increase | 1 | 15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16 | 0 | 0 | 16 |
| Total change | 1 | 15 | 0 | - 26 | - 201 | - 231 | 0 | 1 969 | 20 | 1 546 | 0 | 0 | 1 546 |
| Balance at the end of the period | 1 455 | 5 453 | 0 | 1 756 | - 1 347 | - 138 | 0 | 8 747 | 31 | 15 957 | 1 400 | 0 17 357 |
As an advance payment of the total 2016 dividend, KBC decided to distribute an interim dividend of 1 euro per share (418 million euros in total), paid on 18 November 2016 (already deducted from retained earnings in 3Q 2016).
of which relating to equity method 26 0 0 0 7 32 32
Furthermore, for 2016 the board of directors proposed to the general meeting of shareholders, who approved this on 4 May 2017, that a closing dividend of 1.80 euros is paid out per share entitled to dividend (753 million euros in total). This dividend is deducted from retained earnings and was accounted for in 2Q 2017.
In line with our dividend policy, the Board of 9 August 2017 has decided to pay an interim dividend of 1 euro per share (418 million euros in total), as an advance payment on the total dividend (payment date 17 November 2017) (already deducted from retained earnings in 3Q 2017). Furthermore, for 2017 KBC will additionally propose a closing dividend of 2 euro per share (a total of 837 million euros will be deducted from retained earnings in 2Q 2018 subject to approval) to the Annual Meeting on 3 May 2018. Also a buy-back of 2.7 million shares (roughly 0.2bn EUR) will be proposed to the Annual Meeting (i.e. a pay-out ratio of 59% including the total dividend, AT1 coupon and share buy-back).
Impact acquisition UBB/Interlease: for more information see note 'Main changes in the scope of consolidation' (note 6.6) further in this report.
More details available in the annual report .
The condensed interim financial statements of the KBC Group for the 12 months ended 31 December 2017 have been prepared in accordance with the International Financial Reporting Standards as adopted for use in the European Union ('endorsed IFRS'). The condensed interim financial statements do not include all the information and disclosures required in the annual financial statements and should be read in conjunction with the annual financial statements for the year ended 31 December 2017 and 2016, which have been prepared in accordance with the endorsed IFRSs.
The following amended IFRS became effective on 1 January 2017 but did not affect KBC's financial statements:
The following amended IFRS became effective on 1 January 2017 and had an impact on KBC's financial statements:
• 'Disclosure Initiative' amendments to IAS 7 (Statement of Cash Flows) mean that additional information on material changes in liabilities arising from financing activities, is provided in the notes to the cashflow statement.
The following changes in presentation and accounting policies were applied in 2017:
The following IFRS were issued but not yet effective at year-end 2017. KBC will apply these standards when they become mandatory.
In July 2014, the IASB issued IFRS 9 (Financial Instruments) on the classification and measurement of financial instruments, as a replacement for the relevant requirements of the present IAS 39 (Financial Instruments: Recognition and Measurement). The mandatory effective date for IFRS 9 is 1 January 2018. A project relating to IFRS 9 had been running for some time at KBC and the implementation of the systems and processes was substantially finalised in 2017. KBC will also apply IFRS 9 to its insurance entities and, therefore, not make use of the possibility offered by the IAS Board to temporarily defer implementation of IFRS 9 for its insurance entities. It will make use of transition relief as regards to disclosing comparative information at the date of initial application.
Classification and measurement: classification and measurement of financial assets under IFRS 9 depends on the specific business model in place and the assets' contractual cashflow characteristics. The impact of first time application is due primarily to a rebalancing of part of the treasury bond portfolio (reclassification from 'Available-for-sale' to 'Amortised cost'), the recognition of unrealised gains and losses on a limited number of investments that have failed the contractual cashflow characteristics test, and the reversal of frozen available-for-sale reserves. These frozen reserves existed under IAS 39 due to historical reclassifications out of the 'Available-for-sale' category to the 'Held-to-maturity' or 'Loans and receivables' categories, but need to be reversed on transition to IFRS 9. For equity instruments not held for trading, which are situated mainly in our insurance activities, KBC will apply the overlay approach to eligible equity instruments (reflecting a consistent treatment as under IAS 39). This approach has been provided by the IASB to cover the transition period between the implementation of IFRS 9 and IFRS 17, thus ensuring there is a level playing field with other insurers and bank-insurers.
In May 2017, the IASB issued IFRS 17 (Insurance Contracts), a comprehensive new accounting standard for insurance contracts covering recognition and measurement, presentation and disclosure. Once effective, IFRS 17 will replace IFRS 4 (Insurance Contracts) that was issued in 2005. IFRS 17 applies to all types of insurance contracts (i.e. life, non-life, direct insurance and re-insurance), regardless of the type of entities that issue them, as well as to certain guarantees and financial instruments with discretionary participation features. A few scope exceptions will apply. The overall objective of IFRS 17 is to provide an accounting model for insurance contracts that is more useful and consistent for insurers. In contrast to the requirements in IFRS 4, which are largely based on grandfathering previous local accounting policies, IFRS 17 provides a comprehensive model for insurance contracts, covering all relevant accounting aspects. The core of IFRS 17 is the general model, supplemented by a specific adaptation for contracts with direct participation features (the variable fee approach) and a simplified approach (the premium allocation approach) mainly for short-duration contracts. IFRS 17 will become effective for reporting periods beginning on or after 1 January 2021 (subject to EU endorsement), with comparative figures being required. An impact study is an inherent part of the IFRS 17 project that is currently underway at KBC.
Other
A summary of the main accounting policies is provided in the group's annual accounts as at 31 December 2016.
For a description on the management structure and linked reporting presentation, reference is made to note 2.1 in the annual accounts 2016.
| Business | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| unit | |||||||||
| Business | Business | Interna | |||||||
| unit | unit Czech | tional | of which: | of which: | of which: | of which: | Group | KBC | |
| In millions of EUR | Belgium | Republic | Markets | Hungary | Slovakia | Bulgaria | Ireland | Centre | Group |
| 12M 2017 | |||||||||
| Net interest income | 2 394 | 888 | 837 | 244 | 211 | 104 | 278 | 1 | 4 121 |
| Non-life insurance before reinsurance | 526 | 86 | 83 | 35 | 25 | 23 | 0 | 11 | 706 |
| Earned premiums Non-life | 1 043 | 216 | 224 | 100 | 36 | 88 | 0 | 8 | 1 491 |
| Technical charges Non-life | - 516 | - 130 | - 141 | - 64 | - 12 | - 65 | 0 | 3 | - 785 |
| Life insurance before reinsurance | - 132 | 48 | 25 | 7 | 12 | 5 | 0 | 1 | - 58 |
| Earned premiums Life | 927 | 260 | 85 | 16 | 49 | 20 | 0 | 0 | 1 271 |
| Technical charges Life | - 1 059 | - 212 | - 60 | 1 | - 1 330 | ||||
| - 9 | - 36 | - 15 | 0 | ||||||
| Ceded reinsurance result | - 15 | - 4 | 9 | - 1 | - 2 | 12 | 0 | 1 | - 8 |
| Dividend income | 52 | 0 | 1 | 0 | 0 | 0 | 0 | 10 | 63 |
| Net result from financial instruments at fair value through profit or loss | 539 | 222 | 95 | 62 | 15 | 13 | 5 | - 1 | 856 |
| Net realised result from available-for-sale assets | 123 | 17 | 3 | 2 | 0 | 1 | 0 | 56 | 199 |
| Net fee and commission income | 1 290 | 192 | 232 | 161 | 51 | 18 | - 1 | - 6 | 1 707 |
| Net other income | 174 | 40 | - 112 | 3 | 8 | - 4 | - 116 | 11 | 114 |
| TOTAL INCOME Operating expenses |
4 953 - 2 452 |
1 490 - 646 |
1 173 - 837 |
514 - 346 |
320 - 204 |
172 - 96 |
167 - 188 |
84 - 140 |
7 700 - 4 074 |
| Impairment | - 116 | - 24 | 190 | 8 | - 13 | - 20 | 215 | - 20 | 30 |
| on loans and receivables | - 87 | - 5 | 197 | 11 | - 11 | - 17 | 215 | - 18 | 87 |
| on available-for-sale assets | - 11 | - 1 | - 1 | 0 | 0 | - 1 | 0 | 0 | - 12 |
| on goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| on other | - 18 | - 18 | - 7 | - 3 | - 1 | - 2 | 0 | - 2 | - 45 |
| Share in results of associated companies and joint ventures | - 13 | 21 | 4 | 0 | 0 | 0 | 0 | 0 | 11 |
| RESULT BEFORE TAX Income tax expense |
2 372 - 797 |
842 - 140 |
529 - 85 |
176 - 29 |
103 - 24 |
56 - 6 |
193 - 26 |
- 75 - 71 |
3 667 - 1 093 |
| 1 575 | 702 | 444 | 146 | 79 | 50 | 167 | - 146 | 2 575 | |
| RESULT AFTER TAX Attributable to minority interests |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 1 575 | 702 | 444 | 146 | 79 | 50 | 167 | - 146 | 2 575 | |
| NET RESULT | |||||||||
| 12M 2016 Net interest income |
2 701 | 849 | 740 | 231 | 216 | 48 | 244 | - 32 | 4 258 |
| Non-life insurance before reinsurance | 440 | 78 | 91 | 33 | 21 | 37 | 0 | 18 | 628 |
| Earned premiums Non-life | 1 012 | 190 | 198 | 82 | 32 | 83 | 0 | 10 | 1 410 |
| Technical charges Non-life | - 572 | - 112 | - 107 | - 49 | - 12 | - 46 | 0 | 8 | - 782 |
| Life insurance before reinsurance | - 208 | 36 | 20 | 4 | 12 | 4 | 0 | 0 | - 152 |
| Earned premiums Life | 1 217 | 271 | 89 | 16 | 51 | 22 | 0 | 0 | 1 577 |
| Technical charges Life | - 1 425 | - 234 | - 69 | - 12 | - 39 | - 18 | 0 | 0 | - 1 728 |
| Ceded reinsurance result | - 12 | - 4 | - 6 | - 2 | - 1 | - 3 | 0 | - 17 | - 38 |
| Dividend income | 61 | 0 | 0 | 0 | 0 | 0 | 0 | 15 | 77 |
| Net result from financial instruments at fair value through profit or loss | 329 | 117 | 89 | 66 | 15 | 2 | 6 | 6 | 540 |
| Net realised result from available-for-sale assets | 90 | 48 | 38 | 19 | 16 | 4 | 0 | 13 | 189 |
| Net fee and commission income | 1 070 | 191 | 201 | 157 | 45 | - 4 | - 1 | - 11 | 1 450 |
| Net other income | 208 | 18 | - 1 | 2 | 6 | - 5 | - 4 | 33 | 258 |
| Net other income | 208 | 18 | - 1 | 2 | 6 | - 5 | - 4 | 33 | 258 |
|---|---|---|---|---|---|---|---|---|---|
| TOTAL INCOME | 4 680 | 1 333 | 1 173 | 509 | 330 | 84 | 246 | 25 | 7 211 |
| Operating expenses | - 2 432 | - 608 | - 750 | - 338 | - 199 | - 56 | - 154 | - 158 | - 3 948 |
| Impairment | - 179 | - 24 | 34 | 12 | - 16 | - 6 | 44 | - 32 | - 201 |
| on loans and receivables | - 113 | - 23 | 42 | 15 | - 15 | - 3 | 45 | - 32 | - 126 |
| on available-for-sale assets | - 58 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - 55 |
| on goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| on other | - 8 | - 4 | - 7 | - 3 | 0 | - 3 | - 1 | 0 | - 20 |
| Share in results of associated companies and joint ventures | 0 | 23 | 0 | 0 | 0 | 0 | 0 | 4 | 27 |
| RESULT BEFORE TAX | 2 070 | 724 | 457 | 183 | 115 | 22 | 136 | - 161 | 3 090 |
| Income tax expense | - 637 | - 128 | - 29 | - 54 | - 23 | 0 | 49 | 132 | - 662 |
| RESULT AFTER TAX | 1 433 | 596 | 428 | 130 | 92 | 22 | 184 | - 29 | 2 428 |
| Attributable to minority interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NET RESULT 1 432 596 428 130 92 22 184 - 29 2 427
Note: see part "income tax expense" for more details regarding impact of Belgian Corporate Income Tax reform.
| In millions of EUR | 2017 | 2016 | 4Q 2017 | 3Q 2017 | 4Q 2016 |
|---|---|---|---|---|---|
| Total | 4 121 | 4 258 | 1 029 | 1 039 | 1 057 |
| Interest income | 6 337 | 6 642 | 1 590 | 1 605 | 1 593 |
| Available-for-sale assets | 650 | 703 | 159 | 165 | 172 |
| Loans and receivables | 3 819 | 3 805 | 965 | 976 | 936 |
| Held-to-maturity investments | 853 | 981 | 207 | 207 | 249 |
| Other assets not at fair value | 166 | 79 | 47 | 45 | 18 |
| Subtotal, interest income from financial assets not | |||||
| measured at fair value through profit or loss | 5 488 | 5 568 | 1 378 | 1 393 | 1 375 |
| Financial assets held for trading | 570 | 661 | 130 | 145 | 142 |
| Hedging derivatives | 274 | 288 | 82 | 65 | 68 |
| Other financial assets at fair value through profit or loss | 5 | 124 | 1 | 2 | 9 |
| Interest expense | -2 216 | -2 384 | - 561 | - 566 | - 537 |
| Financial liabilities measured at amortised cost | - 955 | - 870 | - 242 | - 249 | - 197 |
| Other | - 102 | - 33 | - 34 | - 28 | - 21 |
| Subtotal, interest expense for financial liabilities not | |||||
| measured at fair value through profit or loss | -1 057 | - 903 | - 276 | - 277 | - 217 |
| Financial liabilities held for trading | - 643 | - 771 | - 155 | - 154 | - 175 |
| Hedging derivatives | - 479 | - 564 | - 121 | - 126 | - 132 |
| Interest expense on financial asset at Fair Value | 0 | 0 | 0 | 0 | 0 |
| Other financial liabilities at fair value through profit or loss | - 29 | - 139 | - 6 | - 7 | - 11 |
| Net interest expense on defined benefit plans | - 8 | - 6 | - 2 | - 2 | - 2 |
The result from financial instruments at fair value through profit or loss in 4Q 2017 is 52 million euros higher compared to 3Q 2017. The quarter-on-quarter increase is due to:
Compared to 4Q 2016, the result from financial instruments at fair value through profit or loss is 11 million euros higher in 4Q 2017, for a large part explained by:
On a full-year basis, the result from financial instruments at fair value through profit or loss is 316 million euros higher compared to 2016, for a large part explained by:
| In millions of EUR | 2017 | 2016 | 4Q 2017 | 3Q 2017 | 4Q 2016 |
|---|---|---|---|---|---|
| Total | 199 | 189 | 51 | 51 | 8 |
| Breakdown by portfolio | |||||
| Fixed-income securities | 29 | 24 | 5 | 2 | 3 |
| Shares | 170 | 165 | 46 | 49 | 6 |
| In millions of EUR | 2017 | 2016 | 4Q 2017 | 3Q 2017 | 4Q 2016 |
|---|---|---|---|---|---|
| Total | 1 707 | 1 450 | 430 | 408 | 376 |
| Income | 2 615 | 2 101 | 641 | 606 | 552 |
| Expense | - 908 | - 651 | - 210 | - 198 | - 176 |
| Breakdown by type | |||||
| Asset Management Services | 1 232 | 1 013 | 301 | 295 | 270 |
| Income | 1 289 | 1 050 | 316 | 308 | 280 |
| Expense | - 57 | - 37 | - 15 | - 13 | - 10 |
| Banking Services | 764 | 718 | 204 | 187 | 182 |
| Income | 1 267 | 998 | 309 | 283 | 260 |
| Expense | - 502 | - 280 | - 106 | - 96 | - 78 |
| Distribution | - 290 | - 281 | - 75 | - 74 | - 75 |
| Income | 59 | 54 | 15 | 15 | 13 |
| Expense | - 349 | - 335 | - 89 | - 89 | - 88 |
Presentation change to the note Net fee and commission income: in view of a more transparent breakdown of the net fee and commission income, the following breakdown is provided as of 2017 (reference figures restated accordingly):
• Asset management services: include the income and expense relating to management fees and entry fees
| In millions of EUR | 2017 | 2016 | 4Q 2017 | 3Q 2017 | 4Q 2016 |
|---|---|---|---|---|---|
| Total | 114 | 258 | - 14 | 4 | 101 |
| Of which net realised result following | |||||
| The sale of loans and receivables | 3 | 2 | 1 | 0 | 2 |
| The sale of held-to-maturity investments | 3 | 4 | 0 | 0 | 1 |
| The repurchase of financial liabilities measured at amortised cost | 0 | - 7 | 0 | 0 | 0 |
| Other: of which: | 109 | 259 | - 15 | 4 | 98 |
| Income concerning leasing at the KBC Lease-group | 73 | 78 | 14 | 19 | 19 |
| Income from Group VAB | 64 | 69 | 15 | 13 | 16 |
| Tracker mortgage review provision | - 116 | - 4 | - 62 | - 54 | - 4 |
| Impact of surrender of a reinsured contract | 1 | 25 | 1 | 5 | 25 |
| One-off fee paid (Bulgaria) | - 5 | 0 | 0 | - 5 | 0 |
| Settlement of an old legal file (Czech Republic) | 14 | 0 | 0 | 0 | 0 |
Like all major lenders in Ireland, KBC Bank Ireland offered tracker mortgage loans. In KBC Bank Ireland, these were available between 2003 and 2008.
In December 2015, the Central Bank of Ireland ("CBI") requested the Irish banking industry, including KBC Bank Ireland, to undertake a broad and wide ranging examination of tracker mortgage related issues. The purpose of the tracker mortgage review is to identify cases where customers' contractual rights under the terms of their mortgage agreements were not fully honoured and/or lenders did not fully comply with the various requirements and standards regarding disclosure and transparency for the customer. In situations where customer detriment is identified from this examination, the Bank is required to provide appropriate redress and compensation in line with the CBI 'Principles for Redress'. In 2016, the Bank recognised a provision of 4 million euros in respect of redress and compensation for identified impacted customers.
Following further testing and engagement with the CBI during 2017, the KBC Bank Ireland has identified further impacted customers for which redress and compensation is required. During 2017, the Bank recognised an additional provision of 116 million euros (of which 54.4 million euros in 3Q 2017 and 61.5 million euros in 4Q 2017). This represents the best estimate of the potential liability at 31 December 2017. Redress and compensation payments are expected to be made to all impacted customers during 2018.
| Non-technical | ||||
|---|---|---|---|---|
| In millions of EUR | Life | Non-life | account | TOTAL |
| 12M 2017 | ||||
| Earned premiums, insurance (before reinsurance) | 1 273 | 1 510 | 2 784 | |
| Technical charges, insurance (before reinsurance) | - 1 331 | - 785 | - 2 116 | |
| Net fee and commission income | - 20 | - 292 | - 312 | |
| Ceded reinsurance result | 1 | - 9 | - 8 | |
| Operating expenses | - 140 | - 247 | - 3 | - 389 |
| Internal costs claim paid | - 8 | - 56 | - 65 | |
| Administration costs related to acquisitions | - 31 | - 73 | - 103 | |
| Administration costs | - 100 | - 118 | - 218 | |
| Management costs investments | 0 | 0 | - 3 | - 3 |
| Technical result Net interest income |
- 216 | 178 | - 3 564 |
- 41 564 |
| Dividend income | 39 | 39 | ||
| Net result from financial instruments at fair value | - 2 | - 2 | ||
| Net realised result from AFS assets | 84 | 84 | ||
| Net other income | - 10 | - 10 | ||
| Impairments | - 12 | - 12 | ||
| Allocation to the technical accounts | 537 | 87 | - 624 | 0 |
| Technical-financial result | 320 | 265 | 35 | 621 |
| Share in results of associated companies and joint ventures | 4 | 4 | ||
| RESULT BEFORE TAX | 320 | 265 | 39 | 624 |
| Income tax expense | - 187 | |||
| RESULT AFTER TAX | 438 | |||
| attributable to minority interest | 0 | |||
| attributable to equity holders of the parent | 438 | |||
| 12M 2016 | ||||
| Earned premiums, insurance (before reinsurance) | 1 579 | 1 428 | 3 007 | |
| Technical charges, insurance (before reinsurance) | - 1 728 | - 784 | - 2 512 | |
| Net fee and commission income | - 29 | - 272 | - 301 | |
| Ceded reinsurance result | - 1 | - 37 | - 38 | |
| Operating expenses | - 135 | - 242 | - 3 | - 380 |
| Internal costs claim paid | - 8 | - 54 | - 62 | |
| Administration costs related to acquisitions | - 32 | - 80 | - 112 | |
| Administration costs | - 95 | - 108 | - 203 | |
| Management costs investments | 0 | 0 | - 3 | - 3 |
| Technical result | - 315 | 94 | - 3 | - 224 |
| Net interest income | 614 | 614 | ||
| Dividend income | 45 | 45 | ||
| Net result from financial instruments at fair value | - 10 | - 10 | ||
| Net realised result from AFS assets | 56 | 56 | ||
| Net other income | 18 | 18 | ||
| Impairments | - 55 | - 55 | ||
| Allocation to the technical accounts | 558 | 73 | - 631 | 0 |
| Technical-financial result | 242 | 167 | 35 | 445 |
| Share in results of associated companies and joint ventures | 4 | 4 | ||
| RESULT BEFORE TAX | 242 | 167 | 39 | 449 |
| Income tax expense | - 135 | |||
| RESULT AFTER TAX | 314 | |||
| attributable to minority interest | 0 | |||
| attributable to equity holders of the parent | 314 | |||
Note: Figures for premiums exclude the investment contracts without DPF, which roughly coincide with the unit-linked products. Figures are before elimination of transactions between the bank and insurance entities of the group (more information in the 2016 annual accounts).
The technical charges Non-Life include the release the indexation provision for 26 million euros (before tax) in 3Q 2017. More info, see note 1.1.
The technical charges Life include a positive impact of a release of a specific Life reserve (the so-called flashing light reserve in Belgium) for an amount of +23 million euros (before tax) in 3Q 2017. This reserve covers the interest rate risk resulting from the difference between the high guaranteed interest rate and a prescribed interest rate, which is based on the 5-year historic average of the 10Y OLO. As the contracts with a guaranteed interest rate above this prescribed interest rate reach maturity, the need for this reserve declines and as such the reserve can be reduced in line with the run-off of these insurance contracts.
The operating expenses for 4Q 2017 include 41 million euros related to bank (and insurance) levies (18 million euros in 3Q 2017 and 27 million euros in 4Q 2016; 439 million euros in 12M 2017 and 437 million euros in 12M 2016). Application of IFRIC 21 (Levies) has as a consequence that a large part of the levies are taken upfront in expense of the first quarter of the year.
| In millions of EUR | 2017 | 2016 | 4Q 2017 | 3Q 2017 | 4Q 2016 |
|---|---|---|---|---|---|
| Total | 30 | - 201 | - 2 | - 31 | - 73 |
| Impairment on loans and receivables | 87 | - 126 | 30 | - 15 | - 54 |
| Breakdown by type | |||||
| Specific impairments for on-balance-sheet lending | 86 | - 75 | - 2 | 5 | - 45 |
| Provisions for off-balance-sheet credit commitments | - 59 | 8 | - 1 | - 31 | 4 |
| Portfolio-based impairments | 60 | - 58 | 33 | 11 | - 13 |
| Breakdown by business unit | |||||
| Business unit Belgium | - 87 | - 113 | - 12 | - 21 | - 46 |
| Business unit Czech Republic | - 5 | - 23 | 2 | - 1 | - 11 |
| Business unit International Markets | 197 | 42 | 45 | 12 | 8 |
| of which: Hungary | 11 | 15 | 1 | 0 | 1 |
| of which: Slovakia | - 11 | - 15 | - 2 | - 7 | - 7 |
| of which: Bulgaria | - 17 | - 3 | - 7 | - 7 | 1 |
| of which: Ireland | 215 | 45 | 52 | 26 | 12 |
| Group Centre | - 18 | - 32 | - 4 | - 6 | - 5 |
| Impairment on available-for-sale assets | - 12 | - 55 | - 3 | - 6 | - 4 |
| Breakdown by type | |||||
| Shares | - 12 | - 58 | - 3 | - 6 | - 7 |
| Other | 0 | 3 | 0 | 0 | 3 |
| Impairment on goodwill | 0 | 0 | 0 | 0 | 0 |
| Impairment on other | - 45 | - 20 | - 29 | - 11 | - 15 |
| Intangible assets, other than goodwill | - 13 | - 11 | - 12 | - 1 | - 10 |
| Property and equipment and investment property | - 28 | - 7 | - 16 | - 8 | - 5 |
| Held-to-maturity assets | - 1 | - 1 | 0 | 0 | 0 |
| Associated companies and joint ventures | 0 | 0 | 0 | 0 | 0 |
| Other | - 4 | - 1 | 0 | - 2 | 1 |
In 1Q 2017, the income tax expenses were positively influenced by 66 million euros of deferred tax assets (DTA) related to the liquidation of IIB Finance Ireland at KBC Bank NV. According to Belgian tax law, the loss in paid-in capital that KBC Bank sustained as a result of the liquidation of IIB Finance Ireland is tax deductible for the parent company on the date of liquidation, rather than at the time the losses were incurred.
Deferred taxes on temporary differences have been recalculated in 4Q 2017 based both on the new tax rates in Belgium and the timing of their expected reversals. In this regard, management has exercised judgement in deciding which temporary differences are expected to reverse before 2020, on which the tax rate of 29,58 % is applicable, and those temporary differences expected to reverse after 2020 to which the tax rate of 25% is applied.
As a result of the gradual decrease of the tax rate, 4Q17 includes a one-off negative effect in P&L (income tax expense) of 243 million euros which only have a small . positive one-off impact (of roughly +0.1%) on our common equity ratio at the end of 2017 (thanks in part to higher revaluation reserves for available-for-sale assets (after tax) and lower risk-weighted assets resulting from the lower level of outstanding deferred tax assets). In the segment reporting (note 2.2), the 243 million euros is for 158 million euros included in Group Centre (part related to legacy activities) and 85 million euros in Business Unit Belgium (part not related to legacy activities).
Additionally for qualifying dividends, i.e. received from participations in which 10% is held or an acquisition price of 2.5 million euros is paid and the dividend is distributed out of principally taxed profits, a 95% tax exemption existed until income year 2017. Qualified dividends received from 2018 onwards are fully exempt from Belgian Corporate Income Tax. This led to a one-off positive P&L impact of 32 million euros in 4Q17 (included in Group Centre).
We expect this to have a recurring positive impact on the income statement from 2018 onwards, because of the lower tax rate applying to the Belgian group companies and the introduction of a 100% exemption for dividends received (instead of 95%). But partly offset by the negative impact of some offsetting measures, of which the reform of the Notional Interest Deduction regime, currently estimated at roughly 15 million euros.
The impact of the acquisition of UBB/Interlease on the financial assets and liabilities by product is shown in an additional pro forma column 'Total excluding UBB/Interlease' for informational purposes in order to provide a transparent view on the evolution of the financial assets and liabilities excluding this acquisition. For more information see note 'Main changes in the scope of consolidation' (note 6.6) further in this report.
| Held for | Designated at | Available | Loans and | Held to | Hedging | Total excluding | ||
|---|---|---|---|---|---|---|---|---|
| In millions of EUR | trading | fair value | for sale | receivables | maturity | derivatives | Total | UBB/Interlease |
| FINANCIAL ASSETS, 31-12-2017 | ||||||||
| Loans and advances to credit institutions and | ||||||||
| investment firms a | 3 | 0 | 0 | 24 448 - | - | 24 450 | 24 415 | |
| Loans and advances to customers b | 0 | 38 | 0 | 141 464 - | - | 141 502 | 139 707 | |
| Excluding reverse repos | 0 | 38 | 0 | 140 960 - | - | 140 999 | 139 208 | |
| Trade receivables | 0 | 0 | 0 | 3 986 - | - | 3 986 | 3 986 | |
| Consumer credit | 0 | 0 | 0 | 3 857 - | - | 3 857 | 3 519 | |
| Mortgage loans | 0 | 23 | 0 | 60 601 - | - | 60 625 | 59 781 | |
| Term loans | 0 | 15 | 0 | 62 328 - | - | 62 343 | 62 078 | |
| Finance leasing | 0 | 0 | 0 | 5 308 - | - | 5 308 | 5 149 | |
| Current account advances | 0 | 0 | 0 | 4 728 - | - | 4 728 | 4 537 | |
| Securitised loans | 0 | 0 | 0 | 0 - | - | 0 | 0 | |
| Other | 0 | 0 | 0 | 656 - | - | 656 | 656 | |
| Equity instruments | 508 | 0 | 1 658 - | - | - | 2 165 | 2 158 | |
| Investment contracts (insurance) | - | 14 421 | - | - | - | - | 14 421 | 14 421 |
| Debt securities issued by | 1 156 | 24 | 32 498 | 921 | 30 979 | - | 65 578 | 64 838 |
| Public bodies | 955 | 0 | 22 307 | 52 | 29 096 | - | 52 410 | 51 685 |
| Credit institutions and investment firms | 121 | 0 | 4 468 | 125 | 1 177 | - | 5 891 | 5 891 |
| Corporates | 80 | 24 | 5 723 | 744 | 706 | - | 7 277 | 7 263 |
| Derivatives | 5 765 | - | - | - | - | 245 | 6 010 | 6 010 |
| Other | 0 | 0 | 0 | 626 | 0 | 0 | 626 | 626 |
| Total carrying value | 7 431 | 14 484 | 34 156 | 167 458 | 30 979 | 245 | 254 753 | 252 174 |
| a Of which reverse repos |
19 572 | 19 572 | ||||||
| b Of which reverse repos | 504 | 498 |
| Loans and advances to credit institutions and | |||||||
|---|---|---|---|---|---|---|---|
| investment firms a | 6 | 1 | 0 | 16 922 - | - | 16 929 | |
| Loans and advances to customers b | 1 | 77 | 0 | 133 154 - | - | 133 231 | |
| Excluding reverse repos | 1 | 45 | 0 | 132 810 | - | - | 132 856 |
| Trade receivables | 0 | 0 | 0 | 3 549 | - | - | 3 549 |
| Consumer credit | 0 | 0 | 0 | 3 180 | - | - | 3 180 |
| Mortgage loans | 0 | 29 | 0 | 57 307 | - | - | 57 335 |
| Term loans | 0 | 49 | 0 | 59 035 | - | - | 59 083 |
| Finance leasing | 0 | 0 | 0 | 4 916 | - | - | 4 916 |
| Current account advances | 0 | 0 | 0 | 4 640 | - | - | 4 640 |
| Other | 1 | 0 | 0 | 527 - | - | 528 | |
| Equity instruments | 427 | 2 | 1 723 - | - | - | 2 153 | |
| Investment contracts (insurance) | - | 13 693 | - | - | - | - | 13 693 |
| Debt securities issued by | 1 001 | 411 | 34 985 | 1 015 | 33 697 | - | 71 109 |
| Public bodies | 713 | 47 | 22 982 | 16 | 32 131 | - | 55 889 |
| Credit institutions and investment firms | 127 | 174 | 5 032 | 140 | 948 | - | 6 421 |
| Corporates | 161 | 190 | 6 970 | 859 | 618 | - | 8 799 |
| Derivatives | 8 249 | - | - | - | - | 410 | 8 659 |
| Other | 0 | 0 | 0 | 524 - | - | 525 | |
| Total carrying value | 9 683 | 14 184 | 36 708 | 151 615 | 33 697 | 410 | 246 298 |
| a Of which reverse repos |
11 776 | ||||||
| b Of which reverse repos | 376 |
| Held for | Designated at | Hedging | Measured at | Total excluding | ||
|---|---|---|---|---|---|---|
| In millions of EUR | trading | fair value | derivatives | amortised cost | Total | UBB/Interlease |
| FINANCIAL LIABILITIES, 31-12-2017 | ||||||
| Deposits from credit institutions and investment | ||||||
| firms a | 3 | 12 | - | 33 321 | 33 337 | 33 326 |
| Deposits from customers and debt certificates b | 219 | 1 470 | - | 192 279 | 193 968 | 190 968 |
| Excluding repos | 219 | 1 470 | - | 192 019 | 193 708 | 190 708 |
| Demand deposits | 0 | 0 | - | 73 606 | 73 606 | 72 173 |
| Time deposits | 11 | 403 | - | 19 243 | 19 657 | 18 844 |
| Saving accounts | 0 | 0 | - | 56 692 | 56 692 | 55 980 |
| Special deposits | 0 | 0 | - | 2 235 | 2 235 | 2 235 |
| Other deposits | 0 | 0 | - | 549 | 549 | 508 |
| Certificates of deposit | 0 | 14 | - | 22 579 | 22 593 | 22 593 |
| Customer savings certificates | 0 | 0 | - | 1 721 | 1 721 | 1 721 |
| Non-convertible bonds | 208 | 866 | - | 12 323 | 13 397 | 13 397 |
| Non-convertible subordinated liabilities | 0 | 186 | - | 3 330 | 3 516 | 3 516 |
| Liabilities under investment contracts | - | 13 552 | - | 0 | 13 552 | 13 552 |
| Derivatives | 5 868 | 0 | 1 284 | - | 7 152 | 7 151 |
| Short positions | 905 | 0 | - | - | 905 | 905 |
| in equity instruments | 13 | 0 | - | - | 13 | 13 |
| in debt instruments | 892 | 0 | - | - | 892 | 892 |
| Other | 3 | 0 | - | 2 344 | 2 347 | 2 347 |
| Total carrying value | 6 998 | 15 034 | 1 284 | 227 944 | 251 260 | 248 249 |
| a Of which repos | 5 575 | 5 575 | ||||
| b Of which repos | 260 | 260 |
| Deposits from credit institutions and investment | |||||
|---|---|---|---|---|---|
| firms a | 5 | 1 766 | - | 30 248 | 32 020 |
| Deposits from customers and debt certificates b | 541 | 2 134 | - | 175 055 | 177 730 |
| Excluding repos | 536 | 1 869 | - | 175 017 | 177 421 |
| Demand deposits | 0 | 0 | - | 63 427 | 63 427 |
| Time deposits | 117 | 1 100 | - | 21 027 | 22 245 |
| Saving accounts | 0 | 0 | - | 53 328 | 53 328 |
| Special deposits | 0 | 0 | - | 2 056 | 2 056 |
| Other deposits | 0 | 0 | - | 630 | 630 |
| Certificates of deposit | 0 | 14 | - | 16 629 | 16 643 |
| Customer savings certificates | 0 | 0 | - | 1 959 | 1 959 |
| Non-convertible bonds | 424 | 744 | - | 12 889 | 14 057 |
| Non-convertible subordinated liabilities | 0 | 276 | - | 3 109 | 3 385 |
| Liabilities under investment contracts | - | 12 653 | - | 0 | 12 653 |
| Derivatives | 7 334 | - | 1 704 | - | 9 037 |
| Short positions | 665 | 0 | - | - | 665 |
| in equity instruments | 36 | 0 | - | - | 36 |
| in debt instruments | 629 | 0 | - | - | 629 |
| Other | 13 | 0 | - | 2 182 | 2 195 |
| Total carrying value | 8 559 | 16 553 | 1 704 | 207 485 | 234 300 |
| a Of which repos | 9 420 | ||||
| b Of which repos | 309 |
Included in part income statement, volumes and ratio's per business unit.
Included in part income statement, volumes and ratio's per business unit.
For more details on how KBC defines and determines (i) fair value and the fair value hierarchy and (ii) level 3 valuations reference is made to notes 4.4 up to and including 4.7 of the annual accounts 2016.
| Fair value hierarchy | 31-12-2017 | 31-12-2016 | ||||||
|---|---|---|---|---|---|---|---|---|
| In millions of EUR | Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total |
| Financial assets measured at fair value | ||||||||
| Held for trading | 1 122 | 4 402 | 1 907 | 7 431 | 1 034 | 6 585 | 2 064 | 9 683 |
| Designated at fair value | 13 949 | 525 | 10 | 14 484 | 13 377 | 616 | 191 | 14 184 |
| Available for sale | 26 374 | 6 812 | 970 | 34 156 | 31 427 | 3 716 | 1 565 | 36 708 |
| Hedging derivatives | 0 | 245 | 0 | 245 | 0 | 410 | 0 | 410 |
| Total | 41 445 | 11 984 | 2 887 | 56 316 | 45 838 | 11 328 | 3 820 | 60 986 |
| Financial liabilities measured at fair value | ||||||||
| Held for trading | 909 | 3 872 | 2 218 | 6 998 | 665 | 5 659 | 2 234 | 8 559 |
| Designated at fair value | 13 544 | 904 | 585 | 15 034 | 12 652 | 3 344 | 557 | 16 553 |
| Hedging derivatives | 0 | 1 284 | 0 | 1 284 | 0 | 1 704 | 0 | 1 704 |
| Total | 14 453 | 6 060 | 2 803 | 23 316 | 13 318 | 10 707 | 2 791 | 26 815 |
During 2017, a total amount of 2 983 million euros in financial instruments at fair value was transferred from level 1 to level 2. KBC also transferred 176 million euros in financial instruments at fair value from level 2 to level 1. The majority of the transfers is due a change in valuation methodology driven by the implementation in 3Q 2017 of a fully automated process using the BVAL valuation for bonds of KBC Bank, CBC Banque, KBC Insurance and KBC Credit Investments. BVAL is a widely used pricing solution offered by Bloomberg which uses an average of market prices to provide quotes for bonds. The use of BVAL, changes the corresponding fair value levelling.
In 2017, significant movements in financial assets and liabilities classified in level 3 of the fair value hierarchy included the following:
In the assets designated at fair value through profit and loss, the fair value of debt securities decreased by 198 million euros, mainly due to the termination of CDO deals (162 million euros) and transfers out of level 3 (14 million euros) due to changes in liquidity of the instruments and fair value changes. The remaining decrease is a combination of purchases and exchange rate shifts.
The available for sale category dropped with 595 million euros:
| in number of shares | 31-12-2017 | 31-12-2016 |
|---|---|---|
| Ordinary shares | 418 597 567 | 418 372 082 |
| of which ordinary shares that entitle the holder to a dividend payment | 418 597 567 | 418 372 082 |
| of which treasury shares | 64 845 | 2 |
| Other information | ||
| Par value per ordinary share (in EUR) | 3,48 | 3,48 |
| Number of shares issued but not fully paid up | 0 | 0 |
The ordinary shares of KBC Group NV have no nominal value and are quoted on NYSE Euronext (Brussels). The treasury shares at 31 December 2017 almost fully relate to positions in shares of KBC Group to hedge outstanding equity derivatives.
In 2016: no material changes
On 30 December 2016, KBC announced the acquisition of 99,91% of the shares of the United Bulgarian Bank AD and 100% of Interlease EAD in Bulgaria for a total consideration of 610 million euros, without any contingent consideration. On 13 June 2017, KBC completed this acquisition after approval by the relevant regulatory authorities and received anti-trust approval (final total consideration is 609 million euros fully paid in cash).
This transaction substantially strengthens KBC's position in Bulgaria. UBB is Bulgaria's fourth-largest banking group by total assets with market share of 7,4% as at the end of March 2017. UBB caters for approximately 875 000 retail clients with market share of 9,7% in retail loans. UBB also has a strong presence in the corporate banking market with a share of 7,6% in corporate loans. The table below summarizes the provisional fair values of the main assets and liabilities which are part of the acquisition of UBB/Interlease.
The legal merger of CIBank into UBB was approved early February 2018. The new group United Bulgarian Bank AD (UBB) has become the largest bank-insurance group in Bulgaria with a substantial increase in profit contribution. The operational integration of the business entities will be gradually introduced in the coming months. KBC envisages substantial value creation for shareholders through income and cost synergies.
The consolidated figures in these condensed interim financial statements include the impact of this announced acquisition as of 30 June 2017:
UBB and Interlease are part of the operating segment International Markets, country Bulgaria (see note 2).
The impact of this acquisition on the financial assets and liabilities by product is shown in note 4.1: this note includes an additional pro forma column 'Total excluding UBB/Interlease' for informational purposes in order to provide a transparent view on the evolution of the financial assets and liabilities excluding this acquisition.
| in millions of EUR | 31-12-2017 |
|---|---|
| Percentage of shares bought (+) or sold (-) in the relevant year | UBB 99,91% / Interlease 100% |
| For business unit/segment | Bulgaria |
| Deal date (month and year) | June 2017 |
| Incorporation of the result of the company in the result of the group as of: | 01-07-2017 |
| Purchase price or sale price | 609 |
| Cashflow for acquiring or selling companies less cash and cash equivalents acquired | 185 |
| Recognised amounts of identifiable assets acquired and liabilities assumed - provisional fair value (*) | |
| Cash and cash balances with central banks | 693 |
| Financial assets | 2 810 |
| Held for trading | 502 |
| Available for sale | 335 |
| Loans and receivables | 1 973 |
| Tax assets | 12 |
| Investments in associated companies and joint ventures | 17 |
| Investment property | 15 |
| Property and equipment | 20 |
| Goodwill and other intangible assets | 4 |
| Other assets | 20 |
| of which: cash and cash equivalents (included in the assets above) | 801 |
| Financial liabilities | 3 063 |
| Measured at amortised cost | 3 062 |
| Other liabilities | 20 |
| of which: cash and cash equivalents (included in the liabilities above) | 7 |
| (*) after elimination of intragroup transactions within the KBC Group |
| (in millions of EUR) | 2H 2017 | 4Q 2017 | 3Q 2017 |
|---|---|---|---|
| Net interest income | 55 | 27 | 28 |
| Interest income | 59 | 29 | 30 |
| Interest expense | - 4 | - 2 | - 2 |
| Dividend income | 0 | 0 | 0 |
| Net result from financial instruments at fair value through profit or loss | 10 | 4 | 6 |
| Net realised result from available-for-sale assets | 0 | 0 | 0 |
| Net fee and commission income | 23 | 11 | 12 |
| Fee and commission income | 26 | 13 | 13 |
| Fee and commission expense | - 3 | - 1 | - 2 |
| Net other income | - 5 | - 1 | - 4 |
| TOTAL INCOME | 83 | 41 | 42 |
| Operating expenses | - 40 | - 20 | - 20 |
| Staff expenses | - 20 | - 11 | - 10 |
| General administrative expenses | - 17 | - 8 | - 9 |
| Depreciation and amortisation of fixed assets | - 3 | - 1 | - 1 |
| Impairment | - 13 | - 7 | - 7 |
| on loans and receivables | - 12 | - 6 | - 6 |
| on available-for-sale assets | - 1 | 0 | - 1 |
| on goodwill | 0 | 0 | 0 |
| on other | 0 | 0 | 0 |
| Share in results of associated companies and joint ventures | 0 | - 1 | 1 |
| RESULT BEFORE TAX | 30 | 14 | 16 |
| Income tax expense | - 3 | - 1 | - 2 |
| RESULT AFTER TAX | 27 | 13 | 14 |
| Attributable to minority interest | 0 | 0 | 0 |
| Attributable to equity holders of the parent | 27 | 13 | 14 |
Significant non-adjusting events between the balance sheet date (31 December 2017) and the publication of this report (22 February 2018): none.
The main source of credit risk is the loan portfolio of the bank. A snapshot of the banking portfolio is shown in the table below. It includes all payment credit, guarantee credit (except for confirmations of letters of credit and similar export-/import-related commercial credit), standby credit and credit derivatives, granted by KBC to private persons, companies, governments and banks. Bonds held in the investment portfolio are included if they are corporate- or bank-issued, hence government bonds and trading book exposure are not included. Further on in this chapter, extensive information is provided on the credit portfolio of each business unit. Information specifically on sovereign bonds can be found under 'note 6.7 (in the annual accounts 2016)'.
| Credit risk: loan portfolio overview | ||
|---|---|---|
| Total loan portfolio (in billions of EUR) | 31-12-2017 | 31-12-2016 |
| Amount granted | 191 | 181 |
| Amount outstanding 1 | 154 | 148 |
| Total loan portfolio, by business unit (as a % of the portfolio of credit outstanding) | ||
| Belgium | 63% | 65% |
| Czech Republic | 16% | 15% |
| International Markets | 18% | 17% |
| Group Centre | 3% | 3% |
| Total | 100% | 100% |
| Total outstanding loan portfolio sector breakdown | ||
| Private persons | 42.1% | 42.3% |
| Finance and insurance Authorities |
5.2% | 5.7% |
| Corporates | 2.8% | 3.1% |
| services | 49.8% 11.6% |
48.9% 11.5% |
| distribution | 7.6% | 7.6% |
| real estate | 7.0% | 6.9% |
| building & construction agriculture, farming, fishing |
4.2% | 4.2% |
| automotive | 2.8% | 2.8% |
| electricity | 2.3% | 2.2% |
| food producers | 1.7% | 1.6% |
| metals | 1.5% 1.4% |
1.4% 1.4% |
| chemicals | 1.2% | 1.1% |
| shipping | 1.2% | 1.2% |
| machinery & heavy equipment traders |
1.1% | 1.1% |
| hotels, bars & restaurants | 1.0% | 0.9% |
| oil, gas & other fuels | 0.8% | 0.9% |
| electrotechnics | 0.7% 0.6% |
0.7% 0.6% |
| textile & apparel | 0.5% | 0.4% |
| other 2 | 2.6% | 2.5% |
| Total outstanding loan portfolio geographical breakdown | ||
| Home countries | 88.5% | 88.2% |
| Belgium | 55.5% | 56.8% |
| Czech Republic | 14.8% | 14.0% |
| Ireland | 7.8% | 8.9% |
| Slovakia | 4.9% | 4.8% |
| Hungary Bulgaria |
3.3% 2.1% |
3.1% 0.6% |
| Rest of Western Europe | 7.4% | 7.3% |
| France | 1.9% | 1.8% |
| Netherlands | 1.6% | 1.7% |
| Great Britain | 1.1% | 1.1% |
| Spain | 0.5% | 0.6% |
| Luxemburg Germany |
0.6% 0.6% |
0.6% 0.4% |
| other | 1.1% | 1.0% |
| Rest of Central Europe | 0.4% | 0.5% |
| Russia | 0.1% | 0.1% |
| other | 0.4% | 0.4% |
| North America | 1.4% | 1.6% |
| USA Canada |
1.1% 0.3% |
1.4% 0.2% |
| Asia | 0.8% | 0.8% |
| China | 0.3% | 0.3% |
| Hong Kong | 0.2% | 0.2% |
| Singapore | 0.2% | 0.2% |
| other | 0.1% | 0.1% |
| Rest of the world | 1.4% | 1.6% |
| 31-12-2017 | 31-12-2016 |
|---|---|
| Impaired loans (in millions of EUR or %) | ||
|---|---|---|
| Amount outstanding | 9 186 | 10 583 |
| of which: more than 90 days past due | 5 242 | 5 711 |
| Ratio of impaired loans, per business unit | ||
| Belgium | 2.8% | 3.3% |
| Czech Republic | 2.4% | 2.8% |
| International Markets | 19.7% | 25.4% |
| Group Centre | 9.8% | 8.8% |
| Total | 6.0% | 7.2% |
| of which: more than 90 days past due | 3.4% | 3.9% |
| Specific loan loss impairments (in millions of EUR) and Cover ratio (%) | ||
| Specific loan loss impairments | 4 039 | 4 874 |
| of which: more than 90 days past due | 3 361 | 3 603 |
| Cover ratio of impaired loans | ||
| Specific loan loss impairments / impaired loans | 44% | 46% |
| of which: more than 90 days past due | 64% | 63% |
| Cover ratio of impaired loans, mortgage loans excluded | ||
| Specific loan loss impairments / impaired loans, mortgage loans excluded | 54% | 54% |
| of which: more than 90 days past due | 73% | 72% |
| Credit cost, by business unit (%) | ||
| Belgium | 0.09% | 0.12% |
| Czech Republic | 0.02% | 0.11% |
| International Markets | -0.74% | -0.16% |
| Slovakia | 0.16% | 0.24% |
| Hungary | -0.22% | -0.33% |
| Bulgaria | 0.83% | 0.32% |
| Ireland | -1.70% | -0.33% |
| Group Centre | 0.40% | 0.67% |
| Total | -0.06% | 0.09% |
1 Outstanding amount includes all on-balance sheet commitments and off-balance sheet guarantees
2 Other includes corporate sectors not exceeding 0.5% concentration and unidentified sectors
Impaired loans are loans for which full (re)payment of the contractual cash flows is deemed unlikely. This coincides with KBC's Probability-of-Default-classes 10, 11 and 12 (see annual accounts FY 2016 - section on credit risk for more information on PD classification). These impaired loans are equal to 'non-performing loans' under the (new) definition used by EBA.
The loan portfolios of United Bulgarian Bank AD and Interlease EAD are included in the 31 December 2017 figures for a total outstanding amount of 2.3 billion euros. This amount differs from the accounting figure of loans and advances to customers excluding reverse repos mainly since the latter amount is net of impairment. The loan portfolios are assigned to Business Unit International Markets, country Bulgaria and included in all the reported ratio's.
| Loan portfolio Business Unit Belgium | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 31-12-2017, in millions of EUR | Belgium 1 | Foreign branches | Total Business Unit Belgium | ||||||
| Total outstanding amount | 91 816 | 5 989 | 97 805 | ||||||
| Counterparty break down | % outst. | % outst. | % outst. | ||||||
| SME / corporate | 27 473 | 29,9% | 5 989 | 100,0% | 33 463 | 34,2% | |||
| retail | 64 342 | 70,1% | 0 | 0,0% | 64 342 | 65,8% | |||
| o/w private | 35 159 | 38,3% | 0 | 0,0% | 35 159 | 35,9% | |||
| o/w companies | 29 183 | 31,8% | 0 | 0,0% | 29 183 | 29,8% | |||
| Mortgage loans 2 | % outst. | ind. LTV | % outst. | ind. LTV | % outst. | ||||
| total | 33 668 | 36,7% | 60% | 0 | 0,0% | - | 33 668 | 34,4% | |
| o/w FX mortgages | 0 | 0,0% | - | 0 | 0,0% | - | 0 | 0,0% | |
| o/w ind. LTV > 100% | 1 315 | 1,4% | - | 0 | 0,0% | - | 1 315 | 1,3% | |
| Probability of default (PD) | % outst. | % outst. | % outst. | ||||||
| low risk (PD 1-4; 0.00%-0.80%) | 69 799 | 76,0% | 3 715 | 62,0% | 73 515 | 75,2% | |||
| medium risk (PD 5-7; 0.80%-6.40%) | 17 031 | 18,5% | 1 856 | 31,0% | 18 887 | 19,3% | |||
| high risk (PD 8-9; 6.40%-100.00%) | 2 477 | 2,7% | 97 | 1,6% | 2 574 | 2,6% | |||
| impaired loans (PD 10 - 12) | 2 401 | 2,6% | 317 | 5,3% | 2 718 | 2,8% | |||
| unrated | 107 | 0,1% | 5 | 0,1% | 112 | 0,1% | |||
| Overall risk indicators | spec. imp. | % cover | spec. imp. | % cover | spec. imp. | % cover | |||
| outstanding impaired loans | 2 401 | 1 037 | 43,2% | 317 | 169 | 53,5% | 2 718 | 1 207 | 44,4% |
| o/w PD 10 impaired loans | 1 088 | 144 | 13,3% | 222 | 96 | 43,3% | 1 310 | 240 | 18,3% |
| o/w more than 90 days past due (PD 11+12) | 1 313 | 893 | 68,0% | 95 | 74 | 77,3% | 1 408 | 966 | 68,6% |
| all impairments (specific + portfolio based) | n.a. | n.a. | 1 310 | ||||||
| o/w portfolio based impairments | n.a. | n.a. | 103 | ||||||
| o/w specific impairments | 1 037 | 169 | 1 207 | ||||||
| 2016 Credit cost ratio (CCR) | 0,11% | 0,32% | 0,12% | ||||||
| 2017 Credit cost ratio (CCR) | 0,08% | 0,19% | 0,09% | ||||||
1 Belgium = KBC Bank (all retail and corporate credit lending activities except for the foreign branches), CBC, KBC Lease, KBC Commercial Finance,
KBC Credit Investments (part of non-legacy portfolio assigned to BU Belgium)
2 Mortgage loans: only to private persons (as opposed to the accounting figures)
| 31-12-2017, in millions of EUR | For information: ČMSS 3 | |||||
|---|---|---|---|---|---|---|
| Total outstanding amount | 24 348 | 2 468 | (consolidated via equity-method) | |||
| Counterparty break down | % outst. | % outst. | ||||
| SME / corporate | 7 553 | 31,0% | 0 | 0,0% | ||
| retail | 16 795 | 69,0% | 2 468 | 100,0% | ||
| o/w private | 12 093 | 49,7% | 2 456 | 99,5% | ||
| o/w companies | 4 702 | 19,3% | 12 | 0,5% | ||
| Mortgage loans 1 | % outst. | ind. LTV | % outst. | ind. LTV | ||
| total | 10 944 | 45,0% | 65% | 1 919 | 77,7% | 62% |
| o/w FX mortgages | 0 | 0,0% | - | 0 | 0,0% | - |
| o/w ind. LTV > 100% | 260 | 1,1% | - | 80 | 3,2% | - |
| Probability of default (PD) | % outst. | % outst. | ||||
| low risk (PD 1-4; 0.00%-0.80%) | 17 002 | 69,8% | 1 867 | 75,6% | ||
| medium risk (PD 5-7; 0.80%-6.40%) | 5 886 | 24,2% | 369 | 14,9% | ||
| high risk (PD 8-9; 6.40%-100.00%) | 864 | 3,5% | 153 | 6,2% | ||
| impaired loans (PD 10 - 12) | 576 | 2,4% | 79 | 3,2% | ||
| unrated | 21 | 0,1% | 0 | 0,0% | ||
| Overall risk indicators 2 | spec. imp. | % cover | spec. imp. | % cover | ||
| outstanding impaired loans | 576 | 332 | 57,7% | 79 | 41 | 51,6% |
| o/w PD 10 impaired loans | 182 | 61 | 33,6% | 11 | 2 | 15,5% |
| o/w more than 90 days past due (PD 11+12) | 394 | 271 | 68,9% | 68 | 39 | 57,5% |
| all impairments (specific + portfolio based) | 372 | 47 | ||||
| o/w portfolio based impairments | 40 | 6 | ||||
| o/w specific impairments | 332 | 41 | ||||
| 2016 Credit cost ratio (CCR) | 0,11% | n/a | ||||
| 2017 Credit cost ratio (CCR) | 0,02% | 0,16% |
1 Mortgage loans: only to private persons (as opposed to the accounting figures)
2 CCR at country level in local currency
3 ČMSS: pro-rata figures, corresponding with KBC's 55%-participation in ČMSS
| 31-12-2017, in millions of EUR | Ireland | Slovakia | Hungary | Bulgaria | Total Int Markets | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total outstanding amount | 12 128 | 7 307 | 4 973 | 3 289 | 27 711 | ||||||||||
| Counterparty break down | % outst. | % outst. | % outst. | % outst. | % outst. | ||||||||||
| SME / corporate | 1 174 | 9.7% | 2 858 | 39.1% | 2 944 | 59.2% | 968 | 29.4% | 7 960 | 28.7% | |||||
| retail | 10 954 | 90.3% | 4 449 | 60.9% | 2 028 | 40.8% | 2 320 | 70.6% | 19 752 | 71.3% | |||||
| o/w private | 10 941 | 90.2% | 3 596 | 49.2% | 1 859 | 37.4% | 1 271 | 38.7% | 17 667 | 63.8% | |||||
| o/w companies | 13 | 0.1% | 853 | 11.7% | 169 | 3.4% | 1 049 | 31.9% | 2 085 | 7.5% | |||||
| Mortgage loans 1 | % outst. | ind. LTV | % outst. | ind. LTV | % outst. | ind. LTV | % outst. | ind. LTV | % outst. | ||||||
| total | 10 901 | 89.9% | 74% | 3 122 | 42.7% | 67% | 1 695 | 34.1% | 67% | 669 | 20.4% | 70% | 16 388 | 59.1% | |
| o/w FX mortgages | 0 | 0.0% | - | 0 | 0.0% | - | 9 | 0.2% | 133% | 124 | 3.8% | 64% | 133 | 0.5% | |
| o/w ind. LTV > 100% | 1 700 | 14.0% | - | 18 | 0.2% | - | 255 | 5.1% | - | 46 | 1.4% | - | 2 019 | 7.3% | |
| Probability of default (PD) | % outst. | % outst. | % outst. | % outst. | % outst. | ||||||||||
| low risk (PD 1-4; 0.00%-0.80%) | 812 | 6.7% | 5 326 | 72.9% | 2 532 | 50.9% | 806 | 24.5% | 9 483 | 34.2% | |||||
| medium risk (PD 5-7; 0.80%-6.40%) | 5 833 | 48.1% | 1 488 | 20.4% | 1 877 | 37.7% | 1 343 | 40.9% | 10 549 | 38.1% | |||||
| high risk (PD 8-9; 6.40%-100.00%) | 1 234 | 10.2% | 274 | 3.7% | 238 | 4.8% | 287 | 8.7% | 2 032 | 7.3% | |||||
| impaired loans (PD 10 - 12) | 4 249 | 35.0% | 191 | 2.6% | 323 | 6.5% | 710 | 21.6% | 5 473 | 19.7% | |||||
| unrated | 0 | 0.0% | 28 | 0.4% | 4 | 0.1% | 142 | 4.3% | 174 | 0.6% | |||||
| Overall risk indicators 2 | spec. imp. | % cover | spec. imp. | % cover | spec. imp. | % cover | spec. imp. | % cover | spec. imp. | % cover | |||||
| outstanding impaired loans | 4 249 | 1 514 | 35.6% | 191 | 128 | 66.9% | 323 | 190 | 58.8% | 710 | 406 | 57.1% | 5 473 | 2 238 | 40.9% |
| o/w PD 10 impaired loans | 2 163 | 321 | 14.8% | 29 | 12 | 42.8% | 61 | 19 | 31.9% | 94 | 3 | 3.6% | 2 347 | 356 | 15.2% |
| o/w more than 90 days past due (PD 11+12) | 2 086 | 1 193 | 57.2% | 162 | 115 | 71.2% | 262 | 170 | 65.1% | 616 | 402 | 65.3% | 3 126 | 1 881 | 60.2% |
| all impairments (specific + portfolio based) | 1 550 | 140 | 201 | 415 | 2 306 | ||||||||||
| o/w portfolio based impairments | 36 | 12 | 11 | 9 | 69 | ||||||||||
| o/w specific impairments | 1 514 | 128 | 190 | 406 | 2 238 | ||||||||||
| 2016 Credit cost ratio (CCR) | -0.33% | 0.24% | -0.33% | 0.32% | -0.16% | ||||||||||
| 2017 Credit cost ratio (CCR) | -1.70% | 0.16% | -0.22% | 0.83% | -0.74% |
Total Int Markets: total outstanding amount includes a small amount of KBC internal risk sharings which were eliminated at country level
1 Mortgage loans: only to private persons (as opposed to the accounting figures)
2 CCR at country level in local currency
| Total outstanding amount | 4 296 | ||
|---|---|---|---|
| Counterparty break down | % outst. | ||
| SME / corporate | 4 296 | 100.0% | |
| retail | 0 | 0.0% | |
| o/w private | 0 | 0.0% | |
| o/w companies | 0 | 0.0% | |
| Mortgage loans 2 | % outst. | ind. LTV | |
| total | 0 | 0.0% | - |
| o/w FX mortgages | 0 | 0.0% | - |
| o/w ind. LTV > 100% | 0 | 0.0% | - |
| Probability of default (PD) | % outst. | ||
| low risk (PD 1-4; 0.00%-0.80%) | 3 190 | 74.2% | |
| medium risk (PD 5-7; 0.80%-6.40%) | 587 | 13.7% | |
| high risk (PD 8-9; 6.40%-100.00%) | 82 | 1.9% | |
| impaired loans (PD 10 - 12) | 420 | 9.8% | |
| unrated | 18 | 0.4% | |
| Overall risk indicators | spec. Imp. | % cover | |
| outstanding impaired loans | 420 | 262 | 62.5% |
| o/w PD 10 impaired loans | 106 | 21 | 19.7% |
| o/w more than 90 days past due (PD 11+12) | 314 | 242 | 76.9% |
| all impairments (specific + portfolio based) | 288 | ||
| o/w portfolio based impairments | 25 | ||
| o/w specific impairments | 262 | ||
| 2016 Credit cost ratio (CCR) | 0.67% | ||
| 2017 Credit cost ratio (CCR) | 0.40% |
1 Total Group Centre = KBC Credit Investments (part of non-legacy portfolio assigned to BU Group),
ex-Atomium assets, KBC Bank part Group (a.o. activities in wind-down: e.g. ex-Antwerp Diamond Bank)
2 Mortgage loans: only to private persons (as opposed to the accounting figures)
KBC reports its solvency at group, banking and insurance level, calculating it on the basis of IFRS figures and the relevant guidelines issued by the competent regulator.
We report the solvency of the group, the bank and the insurance company based on IFRS data and according to the rules imposed by the regulator. For the KBC group, this implies that we calculate our solvency ratios based on CRR/CRD IV. This regulation entered gradually into force on 1 January 2014, and will be fully implemented by 1 January 2022. The general rule under CRR/CRD IV for insurance participations is that an insurance participation is deducted from common equity at group level, unless the competent authority grants permission to apply a risk weighting instead (Danish compromise). KBC received such permission from the supervisory authority and hence reports its solvency on the basis of a 370% risk weighting being applied to the holdings of own fund instruments of the insurance company, after having deconsolidated KBC Insurance from the group figures.
In addition to the solvency ratios under CRD IV/CRR, KBC is considered a financial conglomerate since it covers both significant banking and insurance activities. Therefore KBC also has to disclose its solvency position as calculated in accordance with the Financial Conglomerate Directive (FICOD; 2002/87/EC. This implies that available capital is calculated on the basis of the consolidated position of the group and the eligible items recognised as such under the prevailing sectorial rules, which are CRR/CRD IV for the banking business and Solvency II for the insurance business. The capital requirement for the insurance business based on Solvency II is multiplied by 12.5 to obtain a risk weighted asset equivalent.
The Internal Rating Based (IRB) approach is since its implementation in 2008 the primary approach to calculate KBC's risk weighted assets. This is, based on a full application of all the CRD IV/CRR rules, used for approximately 92% of the weighted credit risks, of which approx. 86% according to Advanced and approx. 6% according to Foundation approach. The remaining weighted credit risks (ca. 8%) are calculated according to the Standardised approach.
The 2018 minimum CET1 requirement that KBC is to uphold is set at 9.875% (phased-in, Danish Compromise) which includes the CRR/CRD IV minimum requirement (4.5%), the Pillar 2 Requirement (1.75%) and the buffers set by national competent authorities (1.875% Capital Conservation Buffer, 1.50% Systemic Buffer and 0.25% Countercycle Buffer). Furthermore ECB has set a Pillar 2 Guidance of 1.00%. For further information see press release of 22 February 2018 on www.kbc.com.
Following table groups the solvency on the level of KBC Group according to different methodologies and calculation methods, including the deduction method.
| numerator (common equity) |
denominator (total weighted risk volume) |
ratio (%) | ||
|---|---|---|---|---|
| CRDIV, Common Equity ratio | ||||
| Danish Compromise | Phased-in | 15 131 | 91 972 | 16,45% |
| Fully loaded | 15 104 | 92 410 | 16,34% | |
| Deduction Method | Fully loaded | 14 146 | 87 052 | 16,25% |
| Financial Conglomerates Directive | Fully loaded | 15 988 | 106 062 | 15,07% |
| 31-12-2017 | 31-12-2016 | |||
|---|---|---|---|---|
| In millions of EUR | Fully loaded | Phased-in | Fully loaded | Phased-in |
| Total regulatory capital (after profit appropriation) | 18 706 | 18 725 | 17 571 | 17 887 |
| Tier-1 capital | 16 504 | 16 549 | 15 286 | 15 473 |
| Common equity | 15 104 | 15 131 | 13 886 | 14 033 |
| Parent shareholders' equity (after deconsolidating KBC Insurance) | 16 841 | 16 841 | 15 500 | 15 500 |
| Intangible fixed assets (incl deferred tax impact) (-) | - 475 | - 475 | - 400 | - 400 |
| Goodwill on consolidation (incl deferred tax impact) (-) | - 604 | - 604 | - 483 | - 483 |
| Minority interests | 0 | 0 | 0 | 0 |
| AFS revaluation reserve bonds (-) | - 117 | - 206 | ||
| Hedging reserve (cash flow hedges) (-) | 1 339 | 1 339 | 1 356 | 1 356 |
| Valuation diff. in fin. liabilities at fair value - own credit risk (-) | - 1 | - 1 | - 18 | - 18 |
| Value adjustment due to the requirements for prudent valuation (-) | - 124 | - 111 | - 140 | - 109 |
| Dividend payout (-) | - 837 | - 837 | - 753 | - 753 |
| Renumeration of AT1 instruments (-) | - 2 | - 2 | - 2 | - 2 |
| Deduction re. financing provided to shareholders (-) | - 91 | - 91 | - 91 | - 91 |
| IRB provision shortfall (-) | - 268 | - 268 | - 203 | - 203 |
| Deferred tax assets on losses carried forward (-) | - 672 | - 542 | - 879 | - 557 |
| Limit on deferred tax assets from timing differences relying on future profitability | ||||
| and significant participations in financial sector entities (-) | 0 | 0 | 0 | 0 |
| Additional going concern capital | 1 400 | 1 418 | 1 400 | 1 440 |
| Grandfathered innovative hybrid tier-1 instruments | 0 | 18 | 0 | 40 |
| Grandfathered non-innovative hybrid tier-1 instruments | 0 | 0 | 0 | 0 |
| CRR compliant AT1 instruments | 1 400 | 1 400 | 1 400 | 1 400 |
| Minority interests to be included in additional going concern capital | 0 | 0 | 0 | 0 |
| Tier 2 capital | 2 202 | 2 176 | 2 285 | 2 414 |
| IRB provision excess (+) | 316 | 316 | 367 | 362 |
| Subordinated liabilities | 1 886 | 1 860 | 1 918 | 2 053 |
| Total weighted risk volume | 92 410 | 91 972 | 87 782 | 86 878 |
| Banking | 83 117 | 82 679 | 78 482 | 77 579 |
| Insurance | 9 133 | 9 133 | 9 133 | 9 133 |
| Holding activities | 202 | 202 | 198 | 198 |
| Elimination of intercompany transactions | - 43 | - 43 | - 32 | - 32 |
| Solvency ratios | ||||
| Common equity ratio | 16,34% | 16,45% | 15,82% | 16,15% |
| Tier-1 ratio | 17,86% | 17,99% | 17,41% | 17,81% |
| Total capital ratio (*) | 20,24% | 20,36% | 20,02% | 20,59% |
(*) We have called the USD contingent convertible note (CoCo) the 25th of January 2018. Hence, the capital value of the CoCo has already been excluded from Tier-2. The impact of the CoCo call is largely offset by the successful issuance of a Tier 2 benchmark issuance in September 2017.
The tax reform in Belgium had a slight, positive one-off impact (of roughly +0.1%) on our common equity ratio (Danish Compromise Fully loaded) at the end of 2017 (thanks in part to higher revaluation reserves for available-for-sale assets (after tax) and lower risk-weighted assets resulting from the lower level of outstanding deferred tax assets). For more information see note 'Income tax expense' (note 3.12) in the Consolidated financial statements.
| FICOD | 31-12-2017 | 31-12-2016 | ||
|---|---|---|---|---|
| In millions of EUR | Fully loaded | Phased-in | Fully loaded | Phased-in |
| Common Equity | 15 988 | 16 015 | 14 647 | 14 794 |
| Total weighted risk volume | 106 062 | 105 625 | 101 039 | 100 136 |
| Solvency ratio | ||||
| Common equity ratio | 15,07% | 15,16% | 14,50% | 14,77% |
| In millions of EUR | 31-12-2017 | 31-12-2016 |
|---|---|---|
| Tier-1 capital (Danish compromise) | 16 504 | 15 286 |
| Total exposures | 272 373 | 251 891 |
| Total Assets | 292 342 | 275 200 |
| Deconsolidation KBC Insurance | -32 802 | -32 678 |
| Adjustment for derivatives | -3 908 | -5 784 |
| Adjustment for regulatory corrections in determining Basel III Tier-1 capital | -2 235 | -2 197 |
| Adjustment for securities financing transaction exposures | 816 | 1 094 |
| Off-balance sheet exposures | 18 160 | 16 256 |
| Leverage ratio | 6,06% | 6,07% |
The leverage ratio remained largely stable compared to the end of 2016 due to higher total exposures (mainly caused by an increase in reverse repos and cash balances with central banks), compensated by a higher Tier-1 capital (Danish compromise).
As is the case for the KBC group, the solvency of KBC Bank is calculated based on CRR/CRD IV. The solvency of KBC Insurance is calculated on the basis of Solvency II rules as they became effective on 1 January 2016.
The tables below show the tier-1 and CAD ratios calculated under Basel III (CRD IV/CRR) for KBC Bank, as well as the solvency ratio of KBC Insurance under Solvency II.
| KBC Bank consolidated - CRDIV/CRR | 31-12-2017 | 31-12-2016 | ||
|---|---|---|---|---|
| In millions of EUR | Fully loaded | Phased in | Fully loaded | Phased in |
| Total regulatory capital, after profit appropriation | 15 756 | 15 767 | 16 229 | 16 347 |
| Tier-1 capital | 13 484 | 13 521 | 12 625 | 12 803 |
| Of which common equity | 12 077 | 12 091 | 11 219 | 11 348 |
| Tier-2 capital | 2 273 | 2 246 | 3 604 | 3 544 |
| Total weighted risks | 83 117 | 82 679 | 78 482 | 77 579 |
| Credit risk | 68 842 | 68 405 | 65 933 | 65 030 |
| Market risk | 3 361 | 3 361 | 2 417 | 2 417 |
| Operational risk | 10 913 | 10 913 | 10 132 | 10 132 |
| Solvency ratios | ||||
| Common equity ratio | 14,5% | 14,6% | 14,3% | 14,6% |
| Tier-1 ratio | 16,2% | 16,4% | 16,1% | 16,5% |
| CAD ratio (*) | 19,0% | 19,1% | 20,7% | 21,1% |
(*) We have called the USD contingent convertible note (CoCo) the 25th of January 2018. Hence, the capital value of the coco has already been excluded from Tier-2.
| In millions of EUR | 31-12-2017 | 31-12-2016 |
|---|---|---|
| Own Funds | 3 865 | 3 637 |
| Tier 1 | 3 365 | 3 137 |
| IFRS Parent shareholders equity | 3 051 | 2 936 |
| Dividend payout | - 8 | - 103 |
| Deduction intangible assets and goodwill (after tax) | - 128 | - 123 |
| Valuation differences (after tax) | 403 | 349 |
| Volatility adjustment | 43 | 120 |
| Other | 3 | - 42 |
| Tier 2 | 500 | 500 |
| Subordinated liabilities | 500 | 500 |
| Solvency Capital Requirement (SCR) | 1 823 | 1 791 |
| Market risk | 1 602 | 1 589 |
| Non-life | 535 | 531 |
| Life | 630 | 608 |
| Health | 178 | 181 |
| Counterparty | 107 | 87 |
| Diversification | - 905 | - 881 |
| Other | - 324 | - 323 |
| Solvency II ratio | 212% | 203% |
In April 2016, the National Bank of Belgium issued a Belgian specific regulation which limited the loss absorbing capacity of deferred taxes in the calculation of the required capital. Without applying this Belgian specific regulation, the Solvency II ratio of year-end 2016 equals 214%.
On 19 April 2017, the NBB retroactively waived the strict cap on the loss absorbing capacity of deferred taxes in the calculation of the required capital. Belgian insurance companies are now allowed to apply a higher adjustment for deferred taxes, in line with general European standards, if they pass the recoverability test. This is the case for KBC.
Details on our segments or business units are available in the company presentation
.
| Consolidated income statement | |||||
|---|---|---|---|---|---|
| (in millions of EUR) | 4Q 2017 | 3Q 2017 | 2Q 2017 | 1Q 2017 | 4Q 2016 |
| Net interest income | 569 | 589 | 611 | 625 | 651 |
| Non-life insurance before reinsurance | 100 | 153 | 131 | 143 | 122 |
| Earned premiums Non-life | 265 | 263 | 258 | 256 | 257 |
| Technical charges Non-life | - 165 | - 111 | - 127 | - 113 | - 135 |
| Life insurance before reinsurance | - 24 | - 21 | - 43 | - 44 | - 62 |
| Earned premiums Life | 292 | 195 | 199 | 241 | 298 |
| Technical charges Life | - 316 | - 216 | - 242 | - 285 | - 360 |
| Ceded reinsurance result | - 9 | 4 | - 7 | - 2 | - 8 |
| Dividend income | 7 | 9 | 24 | 12 | 15 |
| Net result from financial instruments at fair value through profit or loss | 150 | 106 | 127 | 156 | 174 |
| Net realised result from available-for-sale assets | 34 | 34 | 32 | 23 | 6 |
| Net fee and commission income | 313 | 301 | 331 | 346 | 279 |
| Fee and commission income | 788 | 779 | 947 | 789 | 689 |
| Fee and commission expense | - 475 | - 479 | - 616 | - 443 | - 409 |
| Net other income TOTAL INCOME |
38 1 178 |
51 1 225 |
40 1 245 |
46 1 305 |
66 1 244 |
| Operating expenses | - 566 | - 520 | - 544 | - 822 | - 556 |
| Impairment | - 24 | - 34 | 2 | - 60 | - 60 |
| on loans and receivables | - 12 | - 21 | 4 | - 59 | - 46 |
| on available-for-sale assets | - 3 | - 5 | - 2 | - 1 | - 7 |
| on goodwill | 0 | 0 | 0 | 0 | 0 |
| on other | - 9 | - 8 | - 1 | 0 | - 7 |
| Share in results of associated companies and joint ventures | - 9 | 0 | - 4 | 0 | 0 |
| RESULT BEFORE TAX | 579 | 672 | 698 | 423 | 628 |
| Income tax expense | - 243 | - 217 | - 215 | - 121 | - 189 |
| RESULT AFTER TAX | 335 | 455 | 484 | 301 | 439 |
| Attributable to minority interest | 0 | 0 | 0 | 0 | 0 |
| Attributable to equity holders of the parent | 336 | 455 | 483 | 301 | 439 |
| Banking | 271 | 336 | 385 | 208 | 371 |
| Insurance | 65 | 119 | 98 | 93 | 68 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repo (end of period) | 94 495 | 93 512 | 93 494 | 92 307 | 91 804 |
| Mortgage loans (end of period) | 34 468 | 34 222 | 34 079 | 34 085 | 34 265 |
| Customer deposits and debt certificates excl. repos (end of period) | 132 881 | 128 895 | 129 825 | 127 005 | 125 074 |
| Technial provisions plus unit-linked, life insurance | |||||
| Interest Guaranteed | 13 649 | 13 775 | 13 940 | 14 235 | 14 567 |
| Unit-Linked | 13 370 | 13 115 | 13 161 | 12 952 | 12 760 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 44 611 | 43 988 | 43 329 | 42 797 | 42 566 |
| Required capital, insurance (end of period) | 1 627 | 1 503 | 1 444 | 1 494 | 1 611 |
| Allocated capital (end of period) | 6 267 | 6 078 | 5 950 | 5 945 | 5 974 |
| Return on allocated capital (ROAC) | 22% | 30% | 32% | 20% | 29% |
| Cost/income ratio, banking | 49% | 46% | 45% | 67% | 45% |
| Combined ratio, non-life insurance | 104% | 78% | 86% | 77% | 92% |
| Net interest margin, banking | 1,48% | 1,51% | 1,61% | 1,67% | 1,72% |
| Consolidated income statement | |||||
|---|---|---|---|---|---|
| (in millions of EUR) | 4Q 2017 | 3Q 2017 | 2Q 2017 | 1Q 2017 | 4Q 2016 |
| Net interest income | 234 | 218 | 220 | 216 | 215 |
| Non-life insurance before reinsurance | 21 | 25 | 22 | 18 | 24 |
| Earned premiums Non-life | 59 | 56 | 53 | 49 | 50 |
| Technical charges Non-life | - 38 | - 31 | - 31 | - 30 | - 27 |
| Life insurance before reinsurance | 14 | 12 | 12 | 11 | 10 |
| Earned premiums Life | 96 | 68 | 47 | 48 | 94 |
| Technical charges Life | - 83 | - 56 | - 35 | - 38 | - 84 |
| Ceded reinsurance result | 2 | - 2 | - 2 | - 1 | - 3 |
| Dividend income | 0 | 0 | 0 | 0 | 0 |
| Net result from financial instruments at fair value through profit or loss | 54 | 53 | 65 | 50 | 24 |
| Net realised result from available-for-sale assets | 0 | - 1 | 6 | 11 | 0 |
| Net fee and commission income | 53 | 43 | 47 | 47 | 50 |
| Fee and commission income | 117 | 105 | 106 | 99 | 104 |
| Fee and commission expense | - 63 | - 62 | - 58 | - 52 | - 54 |
| Net other income | 4 | 5 | 5 | 26 | 2 |
| TOTAL INCOME | 383 | 354 | 375 | 378 | 322 |
| Operating expenses | - 177 | - 153 | - 151 | - 165 | - 152 |
| Impairment | - 11 | - 3 | - 11 | 1 | - 11 |
| on loans and receivables | 2 | - 1 | - 7 | 1 | - 11 |
| on available-for-sale assets on goodwill |
- 1 0 |
0 0 |
0 0 |
0 0 |
3 0 |
| on other | - 12 | - 2 | - 3 | 0 | - 3 |
| Share in results of associated companies and joint ventures | 5 | 6 | 6 | 4 | 4 |
| RESULT BEFORE TAX | 200 | 205 | 219 | 218 | 163 |
| Income tax expense | - 33 | - 34 | - 37 | - 37 | - 33 |
| RESULT AFTER TAX | 167 | 170 | 183 | 181 | 131 |
| Attributable to minority interest | 0 | 0 | 0 | 0 | 0 |
| Attributable to equity holders of the parent | 167 | 170 | 183 | 181 | 131 |
| Banking | 157 | 162 | 176 | 174 | 118 |
| Insurance | 10 | 9 | 7 | 7 | 13 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repo (end of period) | 22 303 | 22 155 | 21 520 | 20 253 | 19 552 |
| Mortgage loans (end of period) | 10 653 | 10 245 | 9 867 | 9 273 | 9 077 |
| Customer deposits and debt certificates excl. repos (end of period) | |||||
| 30 246 | 29 529 | 28 925 | 27 770 | 26 183 | |
| Technial provisions plus unit-linked, life insurance | |||||
| Interest Guaranteed | 613 | 601 | 594 | 576 | 575 |
| Unit-Linked | 622 | 556 | 549 | 525 | 525 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 15 397 | 14 855 | 15 039 | 14 386 | 13 664 |
| Required capital, insurance (end of period) | 114 | 118 | 116 | 110 | 103 |
| Allocated capital (end of period) | 1 716 | 1 662 | 1 680 | 1 606 | 1 504 |
| Return on allocated capital (ROAC) | 40% | 42% | 47% | 48% | 36% |
| 45% | 42% | 39% | 43% | 47% | |
| Cost/income ratio, banking | |||||
| Combined ratio, non-life insurance | 96% | 95% | 97% | 100% | 93% |
| Net interest margin, banking | 3,06% | 2,85% | 3,01% | 3,06% | 2,96% |
Consolidated income statement
| (in millions of EUR) | 4Q 2017 | 3Q 2017 | 2Q 2017 | 1Q 2017 | 4Q 2016 |
|---|---|---|---|---|---|
| Net interest income | 228 | 226 | 194 | 189 | 198 |
| Non-life insurance before reinsurance | 27 | 8 | 23 | 25 | 24 |
| Earned premiums Non-life | 57 | 56 | 57 | 53 | 52 |
| Technical charges Non-life | - 31 | - 48 | - 34 | - 28 | - 28 |
| Life insurance before reinsurance | 7 | 6 | 6 | 6 | 7 |
| Earned premiums Life | 23 | 18 | 21 | 23 | 21 |
| Technical charges Life | - 16 | - 12 | - 15 | - 17 | - 14 |
| Ceded reinsurance result | - 2 | 13 | 0 | - 1 | - 2 |
| Dividend income | 0 | 0 | 0 | 0 | 0 |
| Net result from financial instruments at fair value through profit or loss | 23 | 25 | 19 | 28 | 24 |
| Net realised result from available-for-sale assets | 0 | 1 | 0 | 2 | 2 |
| Net fee and commission income | 65 | 65 | 54 | 48 | 50 |
| Fee and commission income | 101 | 100 | 86 | 79 | 80 |
| Fee and commission expense | - 36 | - 36 | - 33 | - 31 | - 31 |
| Net other income TOTAL INCOME |
- 60 288 |
- 57 287 |
1 297 |
4 301 |
2 305 |
| Operating expenses | - 236 | - 206 | - 183 | - 212 | - 189 |
| Impairment | 39 | 11 | 92 | 47 | 3 |
| on loans and receivables | 45 | 12 | 92 | 48 | 8 |
| on available-for-sale assets | 0 | - 1 | 0 | 0 | 0 |
| on goodwill | 0 | 0 | 0 | 0 | 0 |
| on other | - 5 | - 1 | - 1 | 0 | - 5 |
| Share in results of associated companies and joint ventures | 0 | 2 | 1 | 1 | 0 |
| RESULT BEFORE TAX | 91 | 94 | 207 | 137 | 119 |
| Income tax expense | - 17 | - 15 | - 30 | - 22 | 20 |
| RESULT AFTER TAX | 74 | 78 | 177 | 114 | 139 |
| Attributable to minority interest | 0 | 0 | 0 | 0 | 0 |
| Attributable to equity holders of the parent | 74 | 78 | 177 | 114 | 139 |
| Banking | 68 | 71 | 171 | 106 | 135 |
| Insurance | 6 | 7 | 6 | 9 | 5 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repo (end of period) | 24 201 | 23 871 | 23 508 | 21 487 | 21 496 |
| Mortgage loans (end of period) | 15 503 | 14 850 | 14 661 | 14 058 | 13 993 |
| Customer deposits and debt certificates excl. repos (end of period) | |||||
| Technial provisions plus unit-linked, life insurance | 22 663 | 22 056 | 21 714 | 18 539 | 18 344 |
| Interest Guaranteed | 212 | 212 | 215 | 220 | 220 |
| Unit-Linked | 429 | 422 | 419 | 411 | 408 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 19 790 | 19 923 | 19 991 | 17 667 | 17 163 |
| Required capital, insurance (end of period) | 104 | 97 | 94 | 93 | 95 |
| Allocated capital (end of period) | 2 162 | 2 169 | 2 173 | 1 931 | 1 854 |
| Return on allocated capital (ROAC) | 14% | 16% | 36% | 23% | 28% |
| Cost/income ratio, banking | 83% | 72% | 61% | 72% | 61% |
| Combined ratio, non-life insurance | 94% | 98% | 93% | 85% | 98% |
| Net interest margin, banking | 2,84% | 2,83% | 2,72% | 2,67% | 2,70% |
| (in millions of EUR) | 4Q 2017 | 3Q 2017 | 2Q 2017 | 1Q 2017 | 4Q 2016 |
|---|---|---|---|---|---|
| Net interest income | 63 | 63 | 60 | 58 | 59 |
| Non-life insurance before reinsurance | 8 | 9 | 9 | 9 | 9 |
| Earned premiums Non-life | 26 | 26 | 25 | 23 | 22 |
| Technical charges Non-life | - 17 | - 17 | - 15 | - 14 | - 13 |
| Life insurance before reinsurance | 2 | 2 | 2 | 2 | 3 |
| Earned premiums Life | 4 | 4 | 4 | 4 | 4 |
| Technical charges Life | - 2 | - 2 | - 2 | - 2 | - 1 |
| Ceded reinsurance result | 0 | 0 | - 1 | 0 | - 1 |
| Dividend income | 0 | 0 | 0 | 0 | 0 |
| Net result from financial instruments at fair value through profit or loss | 15 | 14 | 14 | 19 | 15 |
| Net realised result from available-for-sale assets | 0 | 0 | 0 | 1 | 0 |
| Net fee and commission income | 43 | 41 | 41 | 37 | 40 |
| Fee and commission income | 63 | 61 | 59 | 55 | 58 |
| Fee and commission expense | - 20 | - 20 | - 18 | - 18 | - 18 |
| Net other income | 3 | 1 | - 1 | 1 | 2 |
| TOTAL INCOME | 134 | 129 | 124 | 127 | 127 |
| Operating expenses | - 86 | - 81 | - 77 | - 101 | - 82 |
| Impairment | - 1 | - 1 | 8 | 1 | 0 |
| on loans and receivables | 1 | 0 | 9 | 1 | 1 |
| on available-for-sale assets on goodwill |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
| on other | - 2 | 0 | 0 | 0 | - 1 |
| Share in results of associated companies and joint ventures | 0 | 0 | 0 | 0 | 0 |
| RESULT BEFORE TAX | 47 | 47 | 55 | 26 | 45 |
| Income tax expense | - 7 | - 8 | - 8 | - 6 | - 21 |
| RESULT AFTER TAX | 39 | 40 | 47 | 20 | 23 |
| Attributable to minority interest | 0 | 0 | 0 | 0 | 0 |
| Attributable to equity holders of the parent | 39 | 40 | 47 | 20 | 23 |
| Banking | 37 | 37 | 46 | 17 | 21 |
| Insurance | 3 | 2 | 2 | 3 | 2 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repo (end of period) | 4 217 | 4 073 | 3 893 | 3 825 | 3 802 |
| Mortgage loans (end of period) | 1 556 | 1 532 | 1 494 | 1 469 | 1 451 |
| Customer deposits and debt certificates excl. repos (end of period) | 7 302 | 6 980 | 6 663 | 6 756 | 6 814 |
| Technial provisions plus unit-linked, life insurance | |||||
| Interest Guaranteed | 55 | 55 | 55 | 55 | 55 |
| Unit-Linked | 298 | 291 | 290 | 285 | 284 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 5 799 | 5 671 | 5 379 | 5 551 | 5 199 |
| Required capital, insurance (end of period) | 37 | 36 | 34 | 34 | 33 |
| Allocated capital (end of period) | 640 | 626 | 593 | 611 | 566 |
| Return on allocated capital (ROAC) | 26% | 25% | 30% | 12% | 15% |
| Cost/income ratio, banking | 64% | 63% | 62% | 81% | 65% |
| Combined ratio, non-life insurance | 101% | 99% | 92% | 84% | 99% |
| Consolidated income statement | |||||
|---|---|---|---|---|---|
| (in millions of EUR) | 4Q 2017 | 3Q 2017 | 2Q 2017 | 1Q 2017 | 4Q 2016 |
| Net interest income | 53 | 52 | 53 | 53 | 56 |
| Non-life insurance before reinsurance | 7 | 6 | 6 | 6 | 5 |
| Earned premiums Non-life | 10 | 9 | 9 | 8 | 9 |
| Technical charges Non-life | - 3 | - 3 | - 3 | - 2 | - 3 |
| Life insurance before reinsurance | 3 | 3 | 3 | 3 | 3 |
| Earned premiums Life | 13 | 10 | 13 | 13 | 12 |
| Technical charges Life | - 10 | - 7 | - 10 | - 9 | - 9 |
| Ceded reinsurance result | - 1 | 0 | 0 | 0 | 0 |
| Dividend income | 0 | 0 | 0 | 0 | 0 |
| Net result from financial instruments at fair value through profit or loss | 3 | 3 | 5 | 4 | 2 |
| Net realised result from available-for-sale assets Net fee and commission income |
0 13 |
0 12 |
0 13 |
0 12 |
1 11 |
| Fee and commission income | 19 | 17 | 18 | 17 | 12 |
| Fee and commission expense | - 5 | - 5 | - 5 | - 4 | - 1 |
| Net other income | 2 | 2 | 2 | 2 | 2 |
| TOTAL INCOME | 80 | 77 | 82 | 81 | 82 |
| Operating expenses | - 56 | - 48 | - 49 | - 50 | - 55 |
| Impairment | - 3 | - 7 | - 1 | - 2 | - 7 |
| on loans and receivables | - 2 | - 7 | - 1 | - 2 | - 7 |
| on available-for-sale assets | 0 | 0 | 0 | 0 | 0 |
| on goodwill | 0 | 0 | 0 | 0 | 0 |
| on other | - 1 | 0 | 0 | 0 | 0 |
| Share in results of associated companies and joint ventures | 0 | 0 | 0 | 0 | 0 |
| RESULT BEFORE TAX | 21 | 22 | 32 | 28 | 20 |
| Income tax expense | - 5 | - 5 | - 7 | - 6 | - 4 |
| RESULT AFTER TAX | 16 | 16 | 25 | 22 | 16 |
| Attributable to minority interest | 0 | 0 | 0 | 0 | 0 |
| Attributable to equity holders of the parent | 16 | 16 | 25 | 22 | 16 |
| Banking | 14 | 14 | 22 | 19 | 14 |
| Insurance | 2 | 3 | 3 | 3 | 2 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repo (end of period) | 6 574 | 6 434 | 6 284 | 6 217 | 6 094 |
| Mortgage loans (end of period) | 2 943 | 2 861 | 2 770 | 2 695 | 2 608 |
| Customer deposits and debt certificates excl. repos (end of period) | 6 066 | 5 714 | 5 820 | 5 745 | 5 739 |
| Technial provisions plus unit-linked, life insurance | |||||
| Interest Guaranteed | 114 | 113 | 113 | 113 | 116 |
| Unit-Linked | 124 | 126 | 125 | 123 | 122 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 4 908 | 4 826 | 4 910 | 4 716 | 4 635 |
| Required capital, insurance (end of period) | 26 | 23 | 23 | 23 | 23 |
| Allocated capital (end of period) | 537 | 525 | 534 | 513 | 499 |
| Return on allocated capital (ROAC) | 12% | 13% | 19% | 17% | 13% |
| Cost/income ratio, banking | 70% | 64% | 60% | 64% | 66% |
| Combined ratio, non-life insurance | 88% | 85% | 82% | 73% | 94% |
| Net interest income 39 40 12 12 13 Non-life insurance before reinsurance 12 - 7 8 10 10 Earned premiums Non-life 22 21 24 21 22 Technical charges Non-life - 10 - 28 - 16 - 12 - 12 Life insurance before reinsurance 2 1 1 1 1 Earned premiums Life 6 4 4 6 5 Technical charges Life - 4 - 2 - 3 - 5 - 4 Ceded reinsurance result - 1 14 0 - 1 - 1 Dividend income 0 0 0 0 0 Net result from financial instruments at fair value through profit or loss 5 7 1 1 1 Net realised result from available-for-sale assets 0 1 0 1 0 Net fee and commission income 10 11 - 1 - 1 - 1 Fee and commission income 18 19 5 5 5 Fee and commission expense - 9 - 8 - 7 - 6 - 6 Net other income 0 - 4 1 0 - 1 TOTAL INCOME 65 64 22 22 21 Operating expenses - 35 - 33 - 13 - 16 - 15 Impairment - 9 - 7 - 3 - 1 - 2 on loans and receivables - 7 - 7 - 3 - 1 1 on available-for-sale assets 0 - 1 0 0 0 on goodwill 0 0 0 0 0 on other - 2 0 0 0 - 3 Share in results of associated companies and joint ventures - 1 1 0 0 0 RESULT BEFORE TAX 21 25 6 5 4 Income tax expense - 2 - 3 0 - 1 1 RESULT AFTER TAX 19 22 5 4 5 Attributable to minority interest 0 0 0 0 0 Attributable to equity holders of the parent 18 22 5 4 5 Banking 17 21 4 3 4 Insurance 2 1 1 1 1 Breakdown Loans and deposits Total customer loans excluding reverse repo (end of period) 2 716 2 695 2 684 826 835 Mortgage loans (end of period) 1 100 660 657 236 234 Customer deposits and debt certificates excl. repos (end of period) 3 903 3 998 3 846 808 792 Technial provisions plus unit-linked, life insurance Interest Guaranteed 43 44 47 52 49 Unit-Linked 7 5 4 3 2 Performance Indicators Risk-weighted assets, banking (end of period, Basel III fully loaded) 2 933 2 886 3 037 842 839 Required capital, insurance (end of period) 41 38 37 37 39 Allocated capital (end of period) 347 338 353 125 125 Return on allocated capital (ROAC) 31% 49% 16% 13% 16% Cost/income ratio, banking 52% 49% 56% 72% 66% Combined ratio, non-life insurance 88% 102% 98% 96% 98% |
(in millions of EUR) | 4Q 2017 | 3Q 2017 | 2Q 2017 | 1Q 2017 | 4Q 2016 |
|---|---|---|---|---|---|---|
| (in millions of EUR) | 4Q 2017 | 3Q 2017 | 2Q 2017 | 1Q 2017 | 4Q 2016 |
|---|---|---|---|---|---|
| Net interest income | 73 | 70 | 69 | 66 | 69 |
| Non-life insurance before reinsurance | 0 | 0 | 0 | 0 | 0 |
| Earned premiums Non-life | 0 | 0 | 0 | 0 | 0 |
| Technical charges Non-life | 0 | 0 | 0 | 0 | 0 |
| Life insurance before reinsurance | 0 | 0 | 0 | 0 | 0 |
| Earned premiums Life | 0 | 0 | 0 | 0 | 0 |
| Technical charges Life | 0 | 0 | 0 | 0 | 0 |
| Ceded reinsurance result | 0 | 0 | 0 | 0 | 0 |
| Dividend income | 0 | 0 | 0 | 0 | 0 |
| Net result from financial instruments at fair value through profit or loss | 1 | 0 | 0 | 5 | 7 |
| Net realised result from available-for-sale assets | 0 | 0 | 0 | 0 | 0 |
| Net fee and commission income | 0 | 0 | 0 | 0 | - 1 |
| Fee and commission income | 2 | 2 | 2 | 1 | 4 |
| Fee and commission expense | - 2 | - 2 | - 2 | - 1 | - 4 |
| Net other income | - 61 | - 55 | 0 | 0 | - 1 |
| TOTAL INCOME | 12 | 16 | 69 | 71 | 75 |
| Operating expenses | - 59 | - 43 | - 42 | - 44 | - 36 |
| Impairment | 52 | 26 | 87 | 50 | 12 |
| on loans and receivables | 52 | 26 | 87 | 50 | 12 |
| on available-for-sale assets | 0 | 0 | 0 | 0 | 0 |
| on goodwill | 0 | 0 | 0 | 0 | 0 |
| on other | 0 | 0 | 0 | 0 | 0 |
| Share in results of associated companies and joint ventures | 0 | 0 | 0 | 0 | 0 |
| RESULT BEFORE TAX | 5 | - 1 | 113 | 76 | 51 |
| Income tax expense | - 3 | 0 | - 14 | - 10 | 44 |
| RESULT AFTER TAX | 3 | - 1 | 99 | 67 | 95 |
| Attributable to minority interest | 0 | 0 | 0 | 0 | 0 |
| Attributable to equity holders of the parent | 3 | - 1 | 99 | 67 | 95 |
| Banking | 3 | - 1 | 99 | 67 | 95 |
| Insurance | 0 | 0 | 0 | 0 | 0 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repo (end of period) | 10 694 | 10 669 | 10 648 | 10 618 | 10 765 |
| Mortgage loans (end of period) | 9 905 | 9 797 | 9 740 | 9 657 | 9 700 |
| Customer deposits and debt certificates excl. repos (end of period) | 5 392 | 5 364 | 5 385 | 5 229 | 4 999 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 6 144 | 6 525 | 6 652 | 6 544 | 6 477 |
| Allocated capital (end of period) | 639 | 679 | 692 | 681 | 664 |
| Return on allocated capital (ROAC) | 2% | -1% | 57% | 38% | 52% |
| Cost/income ratio, banking | 495% | 271% | 62% | 63% | 49% |
| (in millions of EUR) | 4Q 2017 | 3Q 2017 | 2Q 2017 | 1Q 2017 | 4Q 2016 |
|---|---|---|---|---|---|
| Operational costs of the Group activities | - 25 | - 20 | - 14 | - 14 | - 39 |
| Capital and treasury management | - 5 | 5 | 17 | - 18 | 4 |
| Capital and treasury management APC | 18 | - 13 | - 13 | - 9 | - 14 |
| Results companies in rundown | - 22 | 19 | 11 | 83 | 14 |
| Other | - 144 | - 3 | 10 | - 9 | 11 |
| Total net result for the Group Centre | - 179 | - 12 | 12 | 33 | - 24 |
| (in millions of EUR) | 4Q 2017 | 3Q 2017 | 2Q 2017 | 1Q 2017 | 4Q 2016 |
|---|---|---|---|---|---|
| Net interest income | - 2 | 7 | 2 | - 5 | - 7 |
| Non-life insurance before reinsurance | 4 | 3 | 3 | 1 | 8 |
| Earned premiums Non-life | 2 | 2 | 2 | 2 | 3 |
| Technical charges Non-life | 2 | 0 | 1 | - 1 | 5 |
| Life insurance before reinsurance | 3 | 0 | 2 | - 2 | 5 |
| Earned premiums Life | 0 | 0 | 0 | 0 | 0 |
| Technical charges Life | 1 | 0 | 1 | - 1 | 0 |
| Ceded reinsurance result | - 1 | 1 | 0 | 1 | - 2 |
| Dividend income | 1 | 1 | 6 | 2 | 3 |
| Net result from financial instruments at fair value through profit or loss | 8 | - 2 | 37 | - 44 | 2 |
| Net realised result from available-for-sale assets | 16 | 16 | 14 | 9 | 0 |
| Net fee and commission income | - 1 | - 1 | - 1 | - 3 | - 2 |
| Fee and commission income | - 366 | - 379 | - 393 | - 346 | - 318 |
| Fee and commission expense | 364 | 378 | 392 | 343 | 315 |
| Net other income | 3 | 5 | 2 | 1 | 30 |
| TOTAL INCOME | 29 | 30 | 63 | - 38 | 32 |
| Operating expenses | - 43 | - 35 | - 33 | - 29 | - 67 |
| Impairment | - 6 | - 6 | - 11 | 4 | - 5 |
| on loans and receivables | - 4 | - 6 | - 11 | 4 | - 5 |
| on available-for-sale assets | 0 | 0 | 0 | 0 | 0 |
| on goodwill | 0 | 0 | 0 | 0 | 0 |
| on other | - 2 | 0 | 0 | 0 | 0 |
| Share in results of associated companies and joint ventures | 0 | 0 | 0 | 0 | 1 |
| RESULT BEFORE TAX | - 20 | - 11 | 18 | - 63 | - 39 |
| Income tax expense | - 159 | - 1 | - 7 | 96 | 15 |
| RESULT AFTER TAX | - 179 | - 12 | 12 | 33 | - 24 |
| Attributable to minority interest | 0 | 0 | 0 | 0 | 0 |
| Attributable to equity holders of the parent | - 179 | - 12 | 12 | 33 | - 24 |
| Banking | - 166 | 6 | 17 | 38 | - 11 |
| Insurance | - 3 | 2 | 1 | 2 | 11 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 3 478 | 3 636 | 4 058 | 4 407 | 4 186 |
| Risk-weighted assets, insurance (end of period, Basel III fully loaded) | 9 133 | 9 133 | 9 133 | 9 133 | 9 133 |
| Required capital, insurance (end of period) | - 23 | - 9 | 10 | 3 | - 18 |
| Allocated capital (end of period) | 339 | 369 | 432 | 461 | 428 |
Gives an idea of the amount of profit over a certain period that is attributable to one share (and, where applicable, including dilutive instruments).
| Calculation (in millions of EUR) | Reference | 2017 | 2016 |
|---|---|---|---|
| Result after tax, attributable to equity holders of the parent (A) | 'Consolidated income statement' | 2 575 | 2 427 |
| - | |||
| Coupon on the additional tier-1 instruments included in equity (B) | 'Consolidated statement of changes in equity' | - 52 | - 52 |
| / | |||
| Average number of ordinary shares less treasury shares (in millions) in the period (C) | Note 5.10 | 418 | 418 |
| or | |||
| Average number of ordinary shares plus dilutive options less treasury shares in the | 418 | 418 | |
| period (D) | |||
| Basic = (A-B) / (C) (in EUR) | 6,03 | 5,68 | |
| Diluted = (A-B) / (D) (in EUR) | 6,03 | 5,68 |
Gives an insight into the technical profitability (i.e. after eliminating investment returns, among other items) of the non-life insurance business, more particularly the extent to which insurance premiums adequately cover claim payments and expenses. The combined ratio takes ceded reinsurance into account.
| Calculation (in millions of EUR or %) | Reference | 2017 | 2016 |
|---|---|---|---|
| Net technical insurance charges, including the internal cost of settling claims (A) | Note 3.7.1 | 813 | 839 |
| / | |||
| Net earned insurance premiums (B) | Note 3.7.1 | 1 465 | 1 387 |
| + | |||
| Operating expenses (C) | Note 3.7.1 | 482 | 459 |
| / | |||
| Net written insurance premiums (D) | Note 3.7.1 | 1 493 | 1 406 |
| = (A/B)+(C/D) | 87,8% | 93,2% |
A risk-weighted measure of the group's solvency, based on common equity tier-1 capital.
| Calculation (in millions of EUR or %) | Reference | 2017 | 2016 |
|---|---|---|---|
| 'Detailed calculation 'Danish compromise' table in the 'Solvency KBC Group' section.' | |||
| Phased-in* | 16,5% | 16,2% | |
| Fully loaded* | 16,3% | 15,8% |
* CRD IV capital rules are being implemented gradually to allow banks to build up the necessary capital buffers. The capital position of a bank taking into account the transition period is called 'phased-in'. The capital position of a bank based on a full application of all rules as applicable after the transition period is called 'fully loaded'.
Gives an impression of the relative cost efficiency (costs relative to income) of the banking activities.
| Calculation (in millions of EUR or %) | Reference | 2017 | 2016 |
|---|---|---|---|
| Operating expenses of the banking activities (A) | 'Consolidated income statement': component of 'Operating expenses' |
3 570 | 3 437 |
| / Total income of the banking activities (B) |
'Consolidated income statement': component of 'Total income' |
6 587 | 6 238 |
| =(A) / (B) | 54,2% | 55,1% |
Where relevant, we also estimate exceptional and/or non-operating items when calculating the cost/income ratio. The adjustments include: MTM ALM derivatives (fully excluded), bank taxes (including contributions to European Single Resolution Fund) are included pro rata and hence spread over all quarters of the year instead of being recognised for the most part upfront (as required by IFRIC 21) and one-off items. The Cost/Income ratio adjusted for specific items is 54,9% in FY2017 (versus 56,7% in FY 2016).
Indicates the proportion of impaired loans (see 'Impaired loans ratio' for definition) that are covered by impairment charges. Where appropriate, the numerator and denominator in the formula may be limited to impaired loans that are more than 90 days past due.
| Calculation (in millions of EUR or %) | Reference | 2017 | 2016 |
|---|---|---|---|
| Specific impairment on loans (A) | 'Credit risk: loan portfolio overview' table in the 'Credit risk' section |
4 039 | 4 874 |
| / Outstanding impaired loans (B) |
'Credit risk: loan portfolio overview' table in the 'Credit risk' section |
9 186 | 10 583 |
| = (A) / (B) | 44,0% | 46,1% |
Gives an idea of loan impairment charges recognised in the income statement for a specific period (in this case, a year), relative to the total loan portfolio (see 'Loan portfolio' for definition). In the longer term, this ratio can provide an indication of the credit quality of the portfolio.
| Calculation (in millions of EUR or %) | Reference | 2017 | 2016 |
|---|---|---|---|
| Net changes in impairment for credit risks (A) | 'Consolidated income statement': component of | - 87 | 126 |
| 'Impairment' | |||
| / | |||
| Average outstanding loan portfolio (B) | 'Credit risk: loan portfolio overview' table in the 'Credit | 151 681 | 146 257 |
| risk' section | |||
| = (A) / (B) | -0,06% | 0,09% |
Indicates the proportion of impaired loans in the loan portfolio (see 'Loan portfolio' for definition) and, therefore, gives an idea of the creditworthiness of the portfolio. Impaired loans are loans where it is unlikely that the full contractual principal and interest will be repaid/paid. These loans have a KBC default status of PD 10, PD 11 or PD 12 and correspond to the new definition of 'nonperforming' used by the European Banking Authority.
| Calculation (in millions of EUR or %) | Reference | 2017 | 2016 |
|---|---|---|---|
| Amount outstanding of impaired loans (A) | 'Credit risk: loan portfolio overview' table in the 'Credit risk' section |
9 186 | 10 583 |
| / Total outstanding loan portfolio (B) |
'Credit risk: loan portfolio overview in the 'Credit risk' section |
154 160 | 147 526 |
| = (A) / (B) | 6,0% | 7,2% |
Where appropriate, the numerator may be limited to impaired loans that are more than 90 days past due (PD 11 + PD 12).
Gives an idea of the group's solvency, based on a simple non-risk-weighted ratio.
| Calculation (in millions of EUR or %) | Reference | 2017 | 2016 |
|---|---|---|---|
| Regulatory available tier-1 capital (A) | 'Leverage ratio KBC Group (Basel III fully loaded' | 16 504 | 15 286 |
| table in the 'Leverage KBC Group' section | |||
| / | |||
| Total exposure measures (total of non-risk-weighted on and off-balance sheet items, | Based on the Capital Requirements Regulation (CRR) | 272 373 | 251 891 |
| with a number of adjustments) (B) | |||
| = (A) / (B) | 6,1% | 6,1% |
Gives an idea of the bank's liquidity position in the short term, more specifically the extent to which the group is able to overcome liquidity difficulties over a one-month period.
| Calculation (in millions of EUR or %) | Reference | 2017* | 2016 |
|---|---|---|---|
| Stock of high-quality liquid assets (A) | Based on the European Commission's Delegated Act on LCR |
79 850 | 65 400 |
| / Total net cash outflows over the next 30 calendar days (B) |
57 600 | 47 100 | |
| = (A) / (B) | 139% | 139% |
* end of 2017 based on moving average
Liquidity Coverage ratio (LCR) is based on the Delegated Act requirements. From year-end 2017 onwards, KBC discloses 12 months average LCR in accordance to EBA guidelines on LCR disclosure. As such, the LCR level at FY17 is calculated based on 12 months average, whereas the LCR level at FY16 is based on point-in-time calculation. For the purpose of q-o-q comparison, the 12 months average LCR level at 9M17 was at 138%.
Gives an idea of the magnitude of (what are mainly pure, traditional) lending activities.
| Calculation (in millions of EUR or %) | Reference | 2017 | 2016 |
|---|---|---|---|
| Loans and advances to customers (related to the group's banking activities) (A) | Note 4.1, component of 'Loans and advances to customers' |
139 044 | 131 415 |
| - Reverse repos with customers (B) |
Note 4.1 | - 504 | - 376 |
| + Debt instruments issued by corporates and by credit institutions and investment firms (related to the group's banking activities) (C) |
Note 4.1, component of 'Debt instruments issued by corporates and by credit institutions and investment firms' |
6 243 | 7 114 |
| + | |||
| Loans and advances to credit institutions and investment firms (related to the group's banking activities, excluding dealing room activities) (D) + |
Note 4.1, component of 'Loans and advances to credit institutions and investment firms ' |
881 | 952 |
| Financial guarantees granted to clients (E) | Note 6.1, component of 'Financial guarantees given' | 8 235 | 8 279 |
| + | |||
| Impairment on loans (F) | Note 4.2, component of 'Impairment' | 4 058 | 5 094 |
| + | |||
| Other (including accrued interest) (G) | Component of Note 4.1 | - 3 797 | - 4 952 |
| = (A)-(B)+(C)+(D)+(E)+(F)+(G) | 154 160 | 147 526 |
Indicates the extent to which a bank has sufficient own funds and eligible liabilities available for bail-in. MREL and bail-in are based on the idea that shareholders and debt-holders should bear losses first if a bank fails.
| Calculation (in millions of EUR or %) | Reference | 2017 | 2016 |
|---|---|---|---|
| Own funds* and eligible liabilities (issued from KBC Group NV) (A) | Based on BRRD | 22 207 | 18 467 |
| => based on the strategy of KBC to issue MREL eligible instruments from the Holding | |||
| company | |||
| / | |||
| Risk weighted assets (consolidated, Danish compromise method) (B) | 'Consolidated balance sheet' | 92 410 | 87 782 |
| = (A) / (B) | 24,0% | 21,0% | |
* after deconsolidation of KBC Insurance
Gives an idea of the net interest income of the banking activities (one of the most important sources of revenue for the group) relative to the average total interest-bearing assets of the banking activities.
| Calculation (in millions of EUR or %) | Reference | 2017 | 2016 |
|---|---|---|---|
| Net interest income of the banking activities (A) (annualised) | 'Consolidated income statement': component of 'Net interest income' |
3 513 | 3 602 |
| / Average interest-bearing assets of the banking activities (B) |
'Consolidated balance sheet': component of 'Total assets' |
187 216 | 184 117 |
| = (A) (annualised x360/number of calendar days) / (B) | 1,85% | 1,92% | |
Gives an idea of the bank's structural liquidity position in the long term, more specifically the extent to which the group is able to overcome liquidity difficulties over a one-year period.
| Calculation (in millions of EUR or %) | Reference | 2017 | 2016 |
|---|---|---|---|
| Available amount of stable funding (A) | Basel III, the net stable funding ratio (Basel Committee on Banking Supervision publication, October 2014) |
157 700 | 144 150 |
| / | |||
| Required amount of stable funding (B) | 117 300 | 114 950 | |
| = (A) / (B) | 134,5% | 125,4% |
Gives the carrying value of a KBC share, i.e. the value in euros represented by each share in the parent shareholders' equity of KBC.
| Calculation (in millions of EUR or %) | Reference | 2017 | 2016 |
|---|---|---|---|
| Parent shareholders' equity (A) | 'Consolidated balance sheet' | 17 403 | 15 957 |
| / | |||
| Number of ordinary shares less treasury shares (at period-end) (B) | Note 5.10 | 419 | 418 |
| = (A) / (B) (in EUR) | 41,6 | 38,1 |
Gives an idea of the relative profitability of a business unit, more specifically the ratio of the net result to the capital allocated to the business unit.
| Calculation (in millions of EUR or %) Reference |
2017 | 2016 |
|---|---|---|
| BELGIUM BUSINESS UNIT | ||
| Result after tax (including minority interests) of the business unit (A) Note 2.1: Segment reporting based on the management structure |
1 575 | 1 433 |
| / | ||
| The average amount of capital allocated to the business unit is based on the risk weighted assets for the banking activities (under Basel III) and risk-weighted asset equivalents for the insurance activities (under Solvency II) (B) |
6 007 | 6 092 |
| = (A) annualised / (B) | 26,2% | 23,5% |
| CZECH REPUBLIC BUSINESS UNIT | ||
| Result after tax (including minority interests) of the business unit (A) Note 2.1: Segment reporting based on the management structure |
702 | 596 |
| / | ||
| The average amount of capital allocated to the business unit is based on the risk weighted assets for the banking activities (under Basel III) and risk-weighted asset equivalents for the insurance activities (under Solvency II) (B) |
1 620 | 1 455 |
| = (A) annualised / (B) | 43,0% | 40,9% |
| INTERNATIONAL MARKETS BUSINESS UNIT | ||
| Result after tax (including minority interests) of the business unit (A) Note 2.1: Segment reporting based on the management structure |
444 | 428 |
| / | ||
| The average amount of capital allocated to the business unit is based on the risk weighted assets for the banking activities (under Basel III) and risk-weighted asset equivalents for the insurance activities (under Solvency II) (B) |
2 054 | 1 959 |
| = (A) annualised / (B) | 21,6% | 21,9% |
Gives an idea of the relative profitability of the group, more specifically the ratio of the net result to equity.
| Calculation (in millions of EUR or %) | Reference | 2017 | 2016 |
|---|---|---|---|
| Result after tax, attributable to equity holders of the parent (A) (annualised) | 'Consolidated income statement' | 2 575 | 2 427 |
| - | |||
| Coupon on the additional tier-1 instruments included in equity (B) (annualised) | 'Consolidated statement of changes in equity' | - 52 | - 52 |
| / | |||
| Average parent shareholders' equity, excluding the revaluation reserve for available-for | 'Consolidated statement of changes in equity' | 14.926 | 13.415 |
| sale assets (C) | |||
| = (A-B) (annualised) / (C) | 16,9% | 17,7% |
Measures the solvency of the insurance business, calculated under Solvency II.
| Calculation | Reference | 2017 | 2016 |
|---|---|---|---|
| Detailed calculation under 'Solvency II, KBC Insurance consolidated' table in the | 212% | 203% | |
| Solvency banking and insurance activities separately section |
Total assets under management (AuM) comprise third-party assets and KBC group assets managed by the group's various asset management companies (KBC Asset Management, ČSOB Asset Management, etc.), as well as assets under advisory management at KBC Bank. The assets, therefore, consist mainly of KBC investment funds and unit-linked insurance products, assets under discretionary and advisory management mandates of (mainly retail, private banking and institutional) clients, and certain group assets. The size and development of total AuM are major factors behind net fee and commission income (generating entry and management fees) and hence account for a large part of any change in this income line. In that respect, the AuM of a fund that is not sold directly to clients but is instead invested in by another fund or via a discretionary/advisory management portfolio, are also included in the total AuM figure, in view of the related work and any fee income linked to them.
| Calculation (in billions of EUR or quantity) | Reference | 2017 | 2016 |
|---|---|---|---|
| Belgium Business Unit (A) | Company presentation on www.kbc.com | 204,6 | 198,9 |
| + | |||
| Czech Republic Business Unit (B) | 9,6 | 8,5 | |
| + | |||
| International Markets Business Unit (C) | 5,0 | 5,7 | |
| A)+(B)+(C) | 219,2 | 213,1 | |
A risk-weighted measure of the group's solvency, based on total regulatory capital.
| Calculation | 2017 | 2016 |
|---|---|---|
| Detailed calculation in the table 'Danish Compromise' under 'Solvency KBC Group' | ||
| section | ||
| Phased-in* | 20,4% | 20,6% |
| Fully loaded* | 20,2% | 20,0% |
* CRD IV capital rules are being implemented gradually to allow banks to build up the necessary capital buffers. The capital position of a bank taking into account the transition period is called 'phased-in'. The capital position of a bank based on a full application of all rules as applicable after the transition period is called 'fully loaded'.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.